CN115088785B - Preparation method and application of compound fermented traditional Chinese medicine feed additive for preventing and treating aeromonas hydrophila - Google Patents
Preparation method and application of compound fermented traditional Chinese medicine feed additive for preventing and treating aeromonas hydrophila Download PDFInfo
- Publication number
- CN115088785B CN115088785B CN202210754136.6A CN202210754136A CN115088785B CN 115088785 B CN115088785 B CN 115088785B CN 202210754136 A CN202210754136 A CN 202210754136A CN 115088785 B CN115088785 B CN 115088785B
- Authority
- CN
- China
- Prior art keywords
- fermentation
- traditional chinese
- chinese medicine
- compound
- seed liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 199
- 150000001875 compounds Chemical class 0.000 title claims abstract description 126
- 239000003674 animal food additive Substances 0.000 title claims abstract description 86
- 241000607528 Aeromonas hydrophila Species 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 238000000855 fermentation Methods 0.000 claims abstract description 323
- 230000004151 fermentation Effects 0.000 claims abstract description 313
- 239000007788 liquid Substances 0.000 claims abstract description 81
- 102000004190 Enzymes Human genes 0.000 claims abstract description 71
- 108090000790 Enzymes Proteins 0.000 claims abstract description 71
- 239000000843 powder Substances 0.000 claims abstract description 53
- 241000894006 Bacteria Species 0.000 claims abstract description 41
- 241000193830 Bacillus <bacterium> Species 0.000 claims abstract description 37
- 241000186660 Lactobacillus Species 0.000 claims abstract description 33
- 229940039696 lactobacillus Drugs 0.000 claims abstract description 33
- 241000235342 Saccharomycetes Species 0.000 claims abstract description 32
- 239000000463 material Substances 0.000 claims abstract description 30
- 238000000034 method Methods 0.000 claims abstract description 21
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims abstract description 17
- 244000046052 Phaseolus vulgaris Species 0.000 claims abstract description 17
- 238000002156 mixing Methods 0.000 claims abstract description 17
- 229940088598 enzyme Drugs 0.000 claims description 69
- 230000000694 effects Effects 0.000 claims description 50
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 41
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 37
- 239000001963 growth medium Substances 0.000 claims description 31
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 28
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 28
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 28
- 244000063299 Bacillus subtilis Species 0.000 claims description 25
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 25
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 25
- 241000186840 Lactobacillus fermentum Species 0.000 claims description 24
- 229940012969 lactobacillus fermentum Drugs 0.000 claims description 24
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims description 22
- 244000035851 Chrysanthemum leucanthemum Species 0.000 claims description 22
- 241000221079 Euphorbia <genus> Species 0.000 claims description 22
- 108010038851 tannase Proteins 0.000 claims description 20
- 108010059892 Cellulase Proteins 0.000 claims description 17
- 229940106157 cellulase Drugs 0.000 claims description 17
- 239000002609 medium Substances 0.000 claims description 17
- 229940059442 hemicellulase Drugs 0.000 claims description 16
- 108010002430 hemicellulase Proteins 0.000 claims description 16
- 238000009630 liquid culture Methods 0.000 claims description 14
- 239000007787 solid Substances 0.000 claims description 11
- 238000009360 aquaculture Methods 0.000 claims description 10
- 244000144974 aquaculture Species 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- 238000011081 inoculation Methods 0.000 claims description 8
- 241000411851 herbal medicine Species 0.000 claims description 7
- 230000002401 inhibitory effect Effects 0.000 claims description 7
- 230000004913 activation Effects 0.000 claims description 4
- 230000001105 regulatory effect Effects 0.000 claims description 4
- 238000007873 sieving Methods 0.000 claims description 4
- 208000037405 Aeromona infection Diseases 0.000 claims description 2
- 241001465754 Metazoa Species 0.000 abstract description 19
- 238000012258 culturing Methods 0.000 abstract description 11
- 230000036039 immunity Effects 0.000 abstract description 11
- 239000000047 product Substances 0.000 abstract description 10
- 230000009286 beneficial effect Effects 0.000 abstract description 9
- 230000002195 synergetic effect Effects 0.000 abstract description 4
- 239000006041 probiotic Substances 0.000 abstract description 3
- 235000018291 probiotics Nutrition 0.000 abstract description 3
- 230000003213 activating effect Effects 0.000 abstract description 2
- 239000000796 flavoring agent Substances 0.000 abstract description 2
- 235000019634 flavors Nutrition 0.000 abstract description 2
- 239000012467 final product Substances 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 81
- 241000736919 Pelodiscus sinensis Species 0.000 description 53
- 238000002474 experimental method Methods 0.000 description 51
- 230000001580 bacterial effect Effects 0.000 description 43
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 30
- 230000012010 growth Effects 0.000 description 25
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 24
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 23
- 230000001988 toxicity Effects 0.000 description 22
- 231100000419 toxicity Toxicity 0.000 description 22
- 229940126680 traditional chinese medicines Drugs 0.000 description 22
- 230000004044 response Effects 0.000 description 21
- 230000000844 anti-bacterial effect Effects 0.000 description 20
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 20
- 239000000126 substance Substances 0.000 description 19
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 description 18
- 229940015301 baicalein Drugs 0.000 description 18
- 230000001965 increasing effect Effects 0.000 description 18
- 230000008859 change Effects 0.000 description 17
- 244000052616 bacterial pathogen Species 0.000 description 16
- 235000004515 gallic acid Nutrition 0.000 description 15
- 229940074391 gallic acid Drugs 0.000 description 15
- 235000014220 Rhus chinensis Nutrition 0.000 description 14
- 240000003152 Rhus chinensis Species 0.000 description 14
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 12
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 12
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 12
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 12
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 12
- 241000270666 Testudines Species 0.000 description 12
- 229940074393 chlorogenic acid Drugs 0.000 description 12
- 235000001368 chlorogenic acid Nutrition 0.000 description 12
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 12
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 12
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 12
- 229960001285 quercetin Drugs 0.000 description 12
- 235000005875 quercetin Nutrition 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 11
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 11
- 235000009498 luteolin Nutrition 0.000 description 11
- 239000002994 raw material Substances 0.000 description 11
- 241000207929 Scutellaria Species 0.000 description 10
- 239000000654 additive Substances 0.000 description 10
- 239000004310 lactic acid Substances 0.000 description 10
- 235000014655 lactic acid Nutrition 0.000 description 10
- 238000012216 screening Methods 0.000 description 10
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 9
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 230000000996 additive effect Effects 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 8
- 238000013461 design Methods 0.000 description 8
- 239000002054 inoculum Substances 0.000 description 8
- 230000003993 interaction Effects 0.000 description 8
- 230000000968 intestinal effect Effects 0.000 description 8
- 230000004060 metabolic process Effects 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 238000003753 real-time PCR Methods 0.000 description 8
- 238000011160 research Methods 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 8
- 230000004083 survival effect Effects 0.000 description 8
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 7
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 7
- 102000013563 Acid Phosphatase Human genes 0.000 description 7
- 108010051457 Acid Phosphatase Proteins 0.000 description 7
- 102000007330 LDL Lipoproteins Human genes 0.000 description 7
- 108010007622 LDL Lipoproteins Proteins 0.000 description 7
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 7
- 241001194850 Pelodiscus Species 0.000 description 7
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 7
- 240000004534 Scutellaria baicalensis Species 0.000 description 7
- 239000003963 antioxidant agent Substances 0.000 description 7
- 230000003078 antioxidant effect Effects 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 7
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 7
- 229960003321 baicalin Drugs 0.000 description 7
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 230000007423 decrease Effects 0.000 description 7
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 7
- 235000001785 ferulic acid Nutrition 0.000 description 7
- 229940114124 ferulic acid Drugs 0.000 description 7
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 230000036737 immune function Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 241001482311 Trionychidae Species 0.000 description 6
- 238000004364 calculation method Methods 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 238000005457 optimization Methods 0.000 description 6
- 235000013824 polyphenols Nutrition 0.000 description 6
- 230000035755 proliferation Effects 0.000 description 6
- 238000011144 upstream manufacturing Methods 0.000 description 6
- 238000012795 verification Methods 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 102000015779 HDL Lipoproteins Human genes 0.000 description 5
- 108010010234 HDL Lipoproteins Proteins 0.000 description 5
- 238000012408 PCR amplification Methods 0.000 description 5
- 239000003242 anti bacterial agent Substances 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 238000005520 cutting process Methods 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 238000007865 diluting Methods 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 150000008442 polyphenolic compounds Chemical class 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 108010029541 Laccase Proteins 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
- 235000019764 Soybean Meal Nutrition 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 4
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 238000000540 analysis of variance Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 239000004202 carbamide Substances 0.000 description 4
- 229940109239 creatinine Drugs 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 238000005755 formation reaction Methods 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 230000007721 medicinal effect Effects 0.000 description 4
- 239000012452 mother liquor Substances 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- 239000011574 phosphorus Substances 0.000 description 4
- 239000004455 soybean meal Substances 0.000 description 4
- 229940116269 uric acid Drugs 0.000 description 4
- 208000035143 Bacterial infection Diseases 0.000 description 3
- 108010014251 Muramidase Proteins 0.000 description 3
- 102000016943 Muramidase Human genes 0.000 description 3
- 241000237536 Mytilus edulis Species 0.000 description 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 208000022362 bacterial infectious disease Diseases 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000003907 kidney function Effects 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- 229960000274 lysozyme Drugs 0.000 description 3
- 239000004325 lysozyme Substances 0.000 description 3
- 235000010335 lysozyme Nutrition 0.000 description 3
- 229920002521 macromolecule Polymers 0.000 description 3
- 235000020638 mussel Nutrition 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 241000222178 Candida tropicalis Species 0.000 description 2
- 241000235646 Cyberlindnera jadinii Species 0.000 description 2
- 241000208688 Eucommia Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- 240000004980 Rheum officinale Species 0.000 description 2
- 235000008081 Rheum officinale Nutrition 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000006806 disease prevention Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 239000006916 nutrient agar Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 229940081969 saccharomyces cerevisiae Drugs 0.000 description 2
- 229930000044 secondary metabolite Natural products 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- 230000036269 ulceration Effects 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- 208000028906 Abnormal bone structure Diseases 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241000746375 Andrographis Species 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 244000080767 Areca catechu Species 0.000 description 1
- 235000006226 Areca catechu Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 244000003416 Asparagus officinalis Species 0.000 description 1
- 235000005340 Asparagus officinalis Nutrition 0.000 description 1
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
- 241000132012 Atractylodes Species 0.000 description 1
- 108010017443 B 43 Proteins 0.000 description 1
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 101710130006 Beta-glucanase Proteins 0.000 description 1
- 102100032487 Beta-mannosidase Human genes 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 244000306301 Caesalpinia sappan Species 0.000 description 1
- 235000015162 Caesalpinia sappan Nutrition 0.000 description 1
- 108010022172 Chitinases Proteins 0.000 description 1
- 102000012286 Chitinases Human genes 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 241000037740 Coptis chinensis Species 0.000 description 1
- 240000006766 Cornus mas Species 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 101710112752 Cytotoxin Proteins 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 235000015489 Emblica officinalis Nutrition 0.000 description 1
- 206010068516 Encapsulation reaction Diseases 0.000 description 1
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 1
- 101710146739 Enterotoxin Proteins 0.000 description 1
- 101710158368 Extracellular lipase Proteins 0.000 description 1
- 101710089384 Extracellular protease Proteins 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 241000334160 Isatis Species 0.000 description 1
- 241000334154 Isatis tinctoria Species 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241000186605 Lactobacillus paracasei Species 0.000 description 1
- 241000112528 Ligusticum striatum Species 0.000 description 1
- 241000830535 Ligustrum lucidum Species 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 241001236817 Paecilomyces <Clavicipitaceae> Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 241000972673 Phellodendron amurense Species 0.000 description 1
- 244000234609 Portulaca oleracea Species 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 244000179560 Prunella vulgaris Species 0.000 description 1
- 241000206469 Pulsatilla Species 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- 206010061481 Renal injury Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 235000018167 Reynoutria japonica Nutrition 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 241000951473 Schizonepeta Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 244000191422 Terminalia bellirica Species 0.000 description 1
- 235000011517 Terminalia chebula Nutrition 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 101710128940 Triacylglycerol lipase Proteins 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000010564 aerobic fermentation Methods 0.000 description 1
- 230000009603 aerobic growth Effects 0.000 description 1
- 230000004103 aerobic respiration Effects 0.000 description 1
- XKMRRTOUMJRJIA-UHFFFAOYSA-N ammonia nh3 Chemical compound N.N XKMRRTOUMJRJIA-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 1
- 238000003975 animal breeding Methods 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229940107666 astragalus root Drugs 0.000 description 1
- 229940054340 bacillus coagulans Drugs 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 108010055059 beta-Mannosidase Proteins 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000009670 cang er zi wan Substances 0.000 description 1
- KLOIYEQEVSIOOO-UHFFFAOYSA-N carbocromen Chemical compound CC1=C(CCN(CC)CC)C(=O)OC2=CC(OCC(=O)OCC)=CC=C21 KLOIYEQEVSIOOO-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 239000002619 cytotoxin Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000013400 design of experiment Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000147 enterotoxin Substances 0.000 description 1
- 231100000655 enterotoxin Toxicity 0.000 description 1
- 239000002095 exotoxin Substances 0.000 description 1
- 231100000776 exotoxin Toxicity 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000003031 feeding effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 208000030304 gastrointestinal bleeding Diseases 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 208000037806 kidney injury Diseases 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 229940068140 lactobacillus bifidus Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- -1 lignocellulose Natural products 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000002132 lysosomal effect Effects 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000011880 melting curve analysis Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002068 microbial inoculum Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 238000012803 optimization experiment Methods 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 208000005368 osteomalacia Diseases 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 235000008113 selfheal Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000010563 solid-state fermentation Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005211 surface analysis Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/12—Animal feeding-stuffs obtained by microbiological or biochemical processes by fermentation of natural products, e.g. of vegetable material, animal waste material or biomass
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/02—Breeding vertebrates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
- A23K10/37—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/189—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/143—Fermentum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
- C12R2001/125—Bacillus subtilis ; Hay bacillus; Grass bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/25—Lactobacillus plantarum
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/85—Saccharomyces
- C12R2001/865—Saccharomyces cerevisiae
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
- Y02A40/818—Alternative feeds for fish, e.g. in aquacultures
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Animal Husbandry (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Insects & Arthropods (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Physiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Environmental Sciences (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Neurosurgery (AREA)
- Toxicology (AREA)
- Sustainable Development (AREA)
- Biophysics (AREA)
Abstract
The invention belongs to the field of biological feed, and in particular relates to a preparation method and application of a compound fermentation traditional Chinese medicine feed additive for preventing and treating aeromonas hydrophila; the method comprises the following steps: activating the strain, and culturing to obtain bacillus, saccharomycetes and lactobacillus fermentation seed liquid; mixing the ground compound traditional Chinese medicinal materials with bean pulp and secondary powder, adding compound enzyme to obtain a fermentation medium, inoculating bacillus fermentation seed liquid, saccharomycete fermentation seed liquid and lactobacillus fermentation seed liquid, and performing anaerobic fermentation under a closed condition to obtain a final product; the compound Chinese medicinal materials are adopted to carry out the synergistic fermentation of the bacteria and the enzymes, the obtained product can effectively control aeromonas hydrophila, and the feed additive is rich in probiotics, so that the immunity of the cultured animals can be effectively improved, and the feed additive has sour and fragrant flavor and animal preference; and is beneficial to industrial production, convenient to use and store, and has good application prospect.
Description
Technical Field
The invention belongs to the field of biological feeds, and in particular relates to a preparation method of a compound fermentation traditional Chinese medicine feed additive for preventing and treating aeromonas hydrophila and application of the compound fermentation traditional Chinese medicine feed additive in aquaculture.
Background
Aeromonas hydrophila (Aeromonas Hydrophila) is a gram-negative conditional pathogen that is generally nonpathogenic when the water is clean and pollution-free, but whose bacterial virulence is increased when the water quality is deteriorated, it produces many pathogenic substances such as chitinase, extracellular protease, lipase and other enzymes and haemolytoxin, enterotoxin, cytotoxin and other exotoxins. It is also one of the most common and most harmful pathogenic bacteria in the aquaculture process, and once the aquatic animals are infected, gastrointestinal bleeding, body surface ulceration bleeding and other symptoms can occur. And pathogenic bacteria can spread in the culture pond along with the bodies of infected animals, excreta and the like, and the infection is continuously caused, so that the cultured animals die in a piece. To prevent outbreaks of disease, farmers often add excess antibiotics, and with the disablement of antibiotics, there is a need to find an antibiotic substitute. The fermented Chinese herbal medicine is most likely to be an antibiotic substitute for aquaculture, has the characteristics of green and safe Chinese herbal medicine, has the same antibacterial effect on substances such as organic acid, antibacterial peptide and the like generated after fermentation, is rich in abundant live bacteria components, can be planted in intestinal tracts of cultured animals, and can enhance the immunity of the cultured animals.
At present, the fermentation traditional Chinese medicines are partially studied for animal breeding and disease prevention and treatment, but are mainly applied to disease prevention and treatment in the livestock breeding industry, such as patent CN113616715A, patent CN113813345A and the like. The existing literature lacks research on application of fermented traditional Chinese medicines in aquaculture industry, especially prevention and treatment of aeromonas hydrophila which is extremely harmful in aquaculture. In addition, most of the documents lack a process for screening Chinese medicaments when developing fermented Chinese medicament feeds, and the Chinese medicaments are various in variety and different in efficacy, so that different Chinese medicament raw materials are selected for different pathogenic bacteria aiming at different diseases. There are documents that fermented traditional Chinese medicines prepared by inoculating paecilomyces hepialid in a drug-property matrix for fermentation are used for treating diarrhea of weaned pigs, and the fermented traditional Chinese medicines belong to aerobic fermentation, and fermentation is performed in an open way, so that the risk of contamination of the fermentation matrix by mixed bacteria in the air is increased. For example, in the patent CN113648393a, the traditional Chinese medicine and the auxiliary materials are uniformly mixed with the fermentation strains, namely lactobacillus and bacillus subtilis, and are fermented at the same time, but the fermentation strains do not select saccharomycetes to be performed at the same time, and the effect is poor, especially in the aspect of improving the immunity of the cultured animals.
Disclosure of Invention
Aiming at the problems existing in the prior art, the invention provides a preparation method of a compound fermentation traditional Chinese medicine feed additive for preventing and treating aeromonas hydrophila and application thereof in aquaculture; firstly, a large number of antibacterial traditional Chinese medicines for pathogenic bacteria, aeromonas hydrophila, are screened, meanwhile, fermentation strains and enzymes are screened, and the addition proportion of the traditional Chinese medicines and auxiliary materials and the growth relation of the fermentation strains are researched, so that the optimal addition proportion of the traditional Chinese medicines is obtained.
The traditional Chinese medicine with good antibacterial effect on aeromonas hydrophila is obtained through antibacterial experiment screening, proper bacterial enzymes are obtained through screening for fermentation, proper traditional Chinese medicine addition amount is explored through changing the flora change of fermentation strains according to different traditional Chinese medicine addition ratios, the compound traditional Chinese medicine is subjected to fermentation treatment, the medicinal effect components of the compound traditional Chinese medicine are improved or converted into other medicinal effect components easy to absorb, and the feed additive is rich in probiotics and has excellent control effect on aeromonas hydrophila. Meanwhile, the immunity and the intestinal digestion level of the cultured animals can be effectively improved; in a short-term aeromonas hydrophila toxicity attack experiment, the survival rate of young Chinese soft-shelled turtles can be effectively improved.
In order to achieve the aim of the invention, the technical scheme adopted by the invention is as follows:
(1) Preparing a fermentation medium: mixing the compound Chinese medicinal materials, bean pulp and secondary powder, adding cellulase, hemicellulase and tannase, and mixing to obtain a solid fermentation culture medium;
the weight percentages of the components of the fermentation medium are respectively as follows: 10-90% of compound Chinese herbal medicine; 6-54% of bean pulp; 4-36% of secondary powder; the addition amount of the complex enzyme is 0.1-10%; the compound Chinese medicinal materials comprise the following materials in percentage by weight: 4 to 36 percent of baical skullcap root, 2.4 to 21.6 percent of Chinese gall, 2.8 to 25.2 percent of wild chrysanthemum flower and 0.8 to 7.2 percent of humifuse euphorbia herb; the complex enzyme consists of cellulase, hemicellulase and tannase;
(2) Respectively inoculating bacillus, saccharomycetes and lactobacillus into corresponding liquid culture mediums for activation culture to respectively obtain bacillus fermentation seed liquid, saccharomycetes fermentation seed liquid and lactobacillus fermentation seed liquid;
(3) Inoculating the bacillus seed liquid, the saccharomycete seed liquid and the lactobacillus seed liquid obtained in the step (2) into the fermentation culture medium obtained in the step (1), regulating the fermentation temperature and the water content of the culture medium, uniformly mixing to obtain a fermentation mixture, and carrying out anaerobic fermentation under a closed condition to obtain the compound fermentation traditional Chinese medicine feed additive for preventing and treating aeromonas hydrophila infection.
Preferably, the bean pulp in the step (1) needs to be dried and ground into powder for use; the powder is obtained by sieving with a 50-80 mesh sieve; the compound Chinese medicinal materials are ground into powder for use, and the powder is obtained by sieving with a 50-80-mesh sieve.
Preferably, the mass ratio of the cellulase, the hemicellulase and the tannase in the step (1) is 2:2:3; in the complex enzyme, the enzyme activity of the hemicellulase is 5 ten thousand u/g, and the enzyme activities of the cellulase and the tannase are 1 ten thousand u/g.
Preferably, the weight percentages of the components of the fermentation medium in the step (1) are respectively: 50% of compound Chinese herbal medicine; 30% of bean pulp; 20% of secondary powder; the addition amount of the complex enzyme is 1%; the compound Chinese medicinal materials comprise the following materials in percentage by weight: 20% of radix scutellariae, 12% of gallnut, 14% of wild chrysanthemum flower and 4% of humifuse euphorbia herb.
Preferably, the bacillus in the step (2) is bacillus subtilis; the saccharomycete is saccharomyces cerevisiae; the lactobacillus is Lactobacillus plantarum, lactobacillus fermentum, and Lactobacillus rhamnosus.
Preferably, the inoculum size of the bacillus fermentation seed liquid and the saccharomycete fermentation seed liquid in the step (3) is 0.1% -9% of the weight of the fermentation medium (V/W, mL/g; namely, the relation between the seed liquid and the medium is 0.1-9 mL:100 g); the total number of viable bacteria of the bacillus and the saccharomycetes is 1.0x10 8 ~2.8×10 9 cfu/mL; the saccharomycete fermentation seed liquid is saccharomyces cerevisiae fermentation seed liquid;
the lactobacillus fermentation seed liquid is Lactobacillus plantarum fermentation seed liquid, lactobacillus fermentum fermentation seed liquid and Lactobacillus rhamnosus fermentation seed liquid, and the total number of viable bacteria is 1.5X10 8 ~3.5×10 9 cfu/mL, wherein the inoculation amount of the lactobacillus fermentation seed liquid is 0.8% -5.7% (V/W, mL/g) of the weight of the fermentation medium, namely the relationship between the seed liquid and the medium is that0.8~5.7mL:100g);
The volume ratio of the lactobacillus fermentation seed liquid to the bacillus fermentation seed liquid to the saccharomycetes fermentation seed liquid is 2:2:3.
more preferably, the inoculum size of the bacillus fermentation seed liquid and the saccharomycete fermentation seed liquid is 2% (V/W, mL/g) of the weight of the fermentation medium.
Preferably, the water content of the fermentation medium in the step (3) is 40% -60%; the fermentation time is 5-20 days, and the fermentation temperature is 24-38 ℃.
The compound fermented traditional Chinese medicine feed additive prepared by the invention is used for inhibiting aeromonas hydrophila when being added into aquaculture feed; the specific operation is as follows: adding the compound fermented traditional Chinese medicine feed additive into aquatic feed to obtain mixed feed for feeding; the addition amount of the compound fermented traditional Chinese medicine feed additive accounts for 5-25% of the weight of the mixed feed.
The specific screening process of the technical scheme is as follows:
(1) Screening of traditional Chinese medicine raw materials: from 45 antibacterial traditional Chinese medicines (dark plum, asparagus, dogwood, garlic, shizandra berry, coptis chinensis, houttuynia cordata, fructus forsythiae, polygonum cuspidatum, purslane, green tangerine peel, rhizoma anemarrhenae, ash bark, selfheal, sappan wood, humifuse euphorbia herb, chinese pulsatilla root, myrobalan, mugwort leaf, baikal skullcap root, astragalus root, amur corktree bark, chinese gall, wild chrysanthemum flower, glossy privet fruit, largehead atractylodes rhizome, isatis root, ginkgo leaf, dandelion, schizonepeta, chinese angelica, eucommia bark, rhubarb, red paeony root, eucommia leaf, hawthorn fruit, catechu, rehmannia root, liquorice, ligusticum wallichii, honeysuckle, dyers woad leaf, fructus xanthii, pomegranate rind and common andrographis herb), the traditional Chinese medicines with stronger antibacterial effect on aeromonas hydrophila before and after fermentation are obtained through antibacterial experiment screening. The bacteriostasis experiment adopts an agar diffusion method, and the size of a bacteriostasis zone is shown in table 1.
According to experimental results, the humifuse euphorbia herb, the gallnut, the wild chrysanthemum, the rheum officinale and the radix scutellariae have good antibacterial effect, and after fermentation, the antibacterial capability is obviously enhanced. When the fermented traditional Chinese medicine feed additive is prepared through a pre-experiment, the condition that the Chinese soft-shelled turtle does not ingest is found. The possible reasons for the method are bitter in flavor and poor in palatability of the rheum officinale, so that four traditional Chinese medicines of humifuse euphorbia herb, gallnut, wild chrysanthemum flower and baical skullcap root are comprehensively considered as the fermentation raw materials of the compound traditional Chinese medicine.
TABLE 1 size of antibacterial zone of Chinese medicinal materials on Aeromonas hydrophila before and after fermentation
Note that: in each column of the diameter of the inhibition zone before fermentation and after fermentation, the expression difference marked by the same letter is not obvious (P is more than 0.05), and the expression difference marked by different letters is obvious (P is less than 0.05). In each row of the diameters of the bacteriostasis circles before and after fermentation of different traditional Chinese medicines, the representation difference marked by the same letter is not obvious (P is more than 0.05), and the representation difference marked by different letters is obvious (P is less than 0.05). "/" indicates no bacteriostatic effect.
(2) Screening of fermentation strains: different fermentation strains act on the compound traditional Chinese medicine to produce different effects on the compound traditional Chinese medicine. Therefore, further screening of the fermentation strains is necessary to achieve effective improvement of the effective components of the traditional Chinese medicine. Taking compound traditional Chinese medicines, bean pulp and secondary powder as fermentation raw materials; the compound Chinese medicine is prepared with four kinds of Chinese medicinal materials, including humifuse euphorbia herb, chinese gall, wild chrysanthemum flower and skullcap root.
Taking culture bacteria liquid (cultured to logarithmic growth phase) of each single strain for fermentation, adding 10% (V/W, mL/g) of the culture bacteria liquid into a fermentation raw material, adding distilled water to control the water content of the fermentation raw material to be 50% (V/W, mL/g) for stirring uniformly, placing the fermentation raw material into a fermentation bag with one-way air holes, placing the fermentation bag into a 30 ℃ incubator for anaerobic fermentation, fermenting for 7 days to obtain the compound fermented traditional Chinese medicine feed additive, detecting the change of medicinal components of the compound fermented traditional Chinese medicine feed additive, and measuring the change of the medicinal components by adopting an HPLC method.
The method for measuring the effective components of the traditional Chinese medicine comprises the following steps:
a, establishment of chromatographic conditions
The invention establishes a chromatographic condition for simultaneously measuring chlorogenic acid, ferulic acid, baicalein, baicalin, quercetin and luteolin, which comprises the following specific steps: the XueXB-C18 (250 mm multiplied by 4.6mm,5 μm) chromatographic column is adopted, methanol (A) -0.1% phosphoric acid solution (B) is taken as a mobile phase, gradient elution is carried out (0-10 min,15% A-45% A,85% B-55% B; 10-20 min,45% A-57% A,55% B-43% B; 20-40 min,57% A-85% A,43% B-15% B), the detection wavelength is 335nm, the flow rate is 0.8mL/min, the sample injection amount is as follows: 10 mu L.
TABLE 2 gradient elution conditions of six drug effect ingredients
Gallic acid assay chromatographic conditions: the XueXB-C18 (250 mm. Times.4.6 mm,5 μm) column was used, methanol (A) -0.1% phosphoric acid solution (B) was used as mobile phase, and the mobile phase was eluted at the same ratio. Methanol (a) -0.1% phosphoric acid solution (B) =15: 85. the detection wavelength is 270nm, the flow rate is 0.8mL/min, and the sample injection amount is as follows: 10 mu L.
Preparation of standard substance solution
Each standard was precisely weighed to 20mg, and 60% methanol was dissolved to a constant volume of 10mL to be used as a standard mother liquor. And (3) respectively sucking and mixing 1mL of chlorogenic acid, ferulic acid, baicalein, baicalin, quercetin and luteolin standard substance mother liquor to obtain mixed standard substance mother liquor, and placing the mixed standard substance mother liquor in a refrigerator at 4 ℃ for standby after preparation.
Preparation of Chinese medicine extract
Weighing 1g of the compound fermented traditional Chinese medicine feed additive obtained in the step (2) into a 50mL conical flask, and adding 10mL of 60% methanol solution for leaching for 30min. Filtering to obtain supernatant, and storing in refrigerator at 4deg.C.
High performance liquid chromatography of chlorogenic acid, ferulic acid, baicalin, quercetin, luteolin, and mixed control of baicalein and gallic acid standard substance is shown in figure 1 and figure 2; it can be seen that under the condition of the intrinsic color spectrum, each medicinal component can be well separated, and the peak is complete and has good peak shape.
Regression analysis gave a linear relationship between the peak area (y) and the content (x) of each active ingredient, as shown in Table 3.
TABLE 3 Standard Curve of the efficacy Components
Note that: each of the effective components has a good linear relationship with the peak area thereof in the range of 0 to 500 ug.
Wherein the fermentation strain is Saccharomyces cerevisiae, candida utilis, candida tropicalis, bacillus subtilis, bacillus licheniformis, bacillus coagulans, bacillus amyloliquefaciens, bacillus natto, lactobacillus casei, lactobacillus paracasei, lactobacillus rhamnosus, lactobacillus fermentum, lactobacillus bifidus and lactobacillus plantarum respectively;
the fermentation raw materials are as follows (mass percent): 20% of radix scutellariae, 12% of gallnut, 14% of wild chrysanthemum, 4% of humifuse euphorbia herb, 30% of bean pulp and 20% of secondary powder.
The changes of several main medicinal components in the products of each group are measured after 7d fermentation of different single-fungus fermented compound traditional Chinese medicine feeds, and are shown in table 4 (the traditional Chinese medicine used in the experiment and the traditional Chinese medicine used in the enzyme screening experiment for fermentation are different in batches, so that the medicinal components are different, but the traditional Chinese medicine raw materials used in the same batch of experiment are the same, so that the comparison can be performed among experimental batches).
The experimental results can obviously observe that the single-strain fermentation of different strains has obvious difference on the medicinal components in the compound traditional Chinese medicine feed.
In saccharomycetes, it can be observed that several bacteria have different levels of medicinal components such as chlorogenic acid, quercetin, luteolin, baicalein and the like. The two medicinal components of ferulic acid and baicalin are reduced after fermentation. Wherein after fermentation of candida tropicalis single bacteria, the content of gallic acid is reduced, and saccharomyces cerevisiae and candida utilis promote the content of gallic acid in the compound traditional Chinese medicine. Saccharomyces cerevisiae has better fermentation effect as a whole, and can increase chlorogenic acid content to about 5.27 times before fermentation, quercetin about 1.88 times before fermentation, luteolin about 4.38 times before fermentation, baicalein about 2.91 times before fermentation, and gallic acid about 8.22 times before fermentation.
In bacillus, it can be observed that several kinds of bacillus can raise chlorogenic acid, quercetin, luteolin, baicalein and chlorogenic acid content in compound Chinese medicine, and ferulic acid and baicalin content are reduced. Wherein, the bacillus subtilis single-strain fermentation improves the efficacy components of the traditional Chinese medicine with better overall effect, the content of chlorogenic acid is 2.55 times of that before fermentation, and the content of quercetin is 1.71 times of that before fermentation. Luteolin is 4.83 times before fermentation, baicalein is 2.06 times before fermentation, and gallic acid is 4.10 times before fermentation.
Among lactic acid bacteria, the change of the effective components of each lactic acid bacteria is different. Wherein, the lactobacillus fermentum, the lactobacillus plantarum and the lactobacillus rhamnosus perform relatively better when the traditional Chinese medicine is fermented by single bacteria. The lactobacillus fermentum can raise quercetin 2.05 times before fermentation, luteolin 7.14 times before fermentation, baicalein 2.17 times before fermentation, and gallic acid 14.07 times before fermentation. The lactobacillus plantarum can promote quercetin to be 3.37 times before fermentation, promote luteolin to be 8.31 times before fermentation, promote baicalein to be 1.30 times before fermentation, and promote gallic acid to be 14.10 times before fermentation. The lactobacillus rhamnosus can promote chlorogenic acid 5.91 times before fermentation, promote quercetin 2.37 times before fermentation, promote luteolin 9.83 times before fermentation, promote baicalein 1.93 times before fermentation, and promote gallic acid 1.61 times before fermentation.
TABLE 4 content of Chinese medicinal active ingredients in Chinese medicinal additives after fermentation of different strains
Note 1: each column identifies that the same letter indicates that the difference is not significant (P > 0.05) and that the different letters indicate that the difference is significant (P < 0.05).
(3) Screening of enzymes for fermentation: the changes of several main medicinal components in each group were measured after 7d fermentation of different single enzyme fermented compound traditional Chinese medicine feed additives, and the specific results are shown in table 5.
From the measurement results, it can be observed that:
1. laccase addition is only beneficial to improving chlorogenic acid components in the compound traditional Chinese medicine, but reduces other medicinal components such as ferulic acid, baicalin, quercetin, baicalein and gallic acid, unlike enzyme-free addition groups. If the baicalein is 1.33mg/g after fermentation, the baicalein is only 37.89% of the enzyme-free fermentation group; the content of gallic acid after fermentation was 2.50mg/g, which was 83.06% of that of the enzyme-free fermentation group. The possible reason is that laccase, though being widely used as a commercial enzyme for degrading lignin, can degrade some phenolic substances in plants, and in the research formula, the substances with main pharmacodynamic effects are all polyphenol substances, so that the laccase is degraded to a certain extent in the fermentation and enzymolysis process, and the pharmacodynamic ingredients are reduced.
2. The hemicellulase added can raise baicalein content to 4.81mg/g, which is 16.62 times that before fermentation, 137.04% that before fermentation, and gallic acid to 4.12mg/g, which is 10.84 times that before fermentation, which is 136.88% that before fermentation.
3. The addition of cellulase improves chlorogenic acid to 0.37mg/g, which is 3.36 times before fermentation, 68.18% compared with the control group without enzyme, improves baicalein content to 3.69mg/g, which is 12.30 times before fermentation, and improves gallic acid content to 3.61mg/g, which is 9.5 times before fermentation, which is 119.93% compared with the control group without enzyme.
4. The tannic acid content can be greatly improved by adding tannase, and after fermentation, the gallic acid content is 5.72mg/g, which is 15.05 times of that before fermentation and is 190.03 percent of that of the non-enzyme control group. In addition, the method has a certain effect on increasing the content of baicalein, and can increase the content of baicalein to 3.97mg/g, which is 13.23 times that of the prior fermentation, and 113.11% of the enzyme-free control group. According to the experimental results, except that the lacquer enzyme has no great effect on the increase of main medicinal components in the traditional Chinese medicine, other enzymes such as hemicellulase, cellulase and tannase have gain effects on the increase of the main medicinal components in the traditional Chinese medicine feed, so that the hemicellulase, the cellulase and the tannase are selected as enzymes for fermentation.
TABLE 5 content of Chinese medicinal active ingredients in Chinese medicinal additives after fermentation with different enzymes
Note 1: each column identifies that the same letter indicates that the difference is not significant (P > 0.05) and that the different letters indicate that the difference is significant (P < 0.05).
(4) Determination of the optimal drug addition ratio
The antibacterial experiment results show that the traditional Chinese medicines selected by the formula have broad-spectrum antibacterial effect and can have certain influence on fermentation strains, so that a proper traditional Chinese medicine adding proportion needs to be determined, so that the antibacterial effect of the antibacterial traditional Chinese medicines can be exerted, and the fermentation strains can grow.
According to the invention, by changing the adding proportion of different compound traditional Chinese medicinal materials in fermentation and adopting a PMA-qPCR detection method, the number of viable bacteria of fermentation strains in different groups of traditional Chinese medicinal material adding proportion in the fermentation process is measured, the relation between the compound traditional Chinese medicinal materials and the fermentation strains is explored, and a group of traditional Chinese medicinal material adding proportion which does not influence the growth of fermentation strains and can exert the antibacterial effect of the traditional Chinese medicines is searched.
The baikal skullcap root, humifuse euphorbia herb, wild chrysanthemum flower and Chinese gall are mixed according to a certain proportion (namely 40 percent of baikal skullcap root, 24 percent of Chinese gall, 28 percent of wild chrysanthemum flower and 8 percent of humifuse euphorbia herb) to form a compound traditional Chinese medicine premix. Mixing bean pulp and secondary powder (60% of bean pulp and 40% of secondary powder) according to a certain proportion to obtain auxiliary material premix; seven groups of experiments are designed, a mixture of compound traditional Chinese medicine and auxiliary material premix is used as a fermentation raw material, the mass sum of the compound traditional Chinese medicine and the auxiliary material premix is 100%, wherein the adding mass ratio of the compound traditional Chinese medicine premix is 0%, 10%, 30%, 50%, 70%, 90% and 100% respectively; the fermentation strain is added in the form of bacterial liquid (cultured to a stable period), the addition amount is 2 percent (V/W, mL/g) of the fermentation raw material, the water content is 50 percent, and the fermentation temperature is 30 ℃ to obtain the fermentation feed additive; the change in the flora during fermentation was determined by means of PMA-qPCR.
Measurement of the amount of fermentation strain
A. Genome extraction: taking 1mL of seed solution (cultured to logarithmic growth phase) of each fermentation strain (bacillus subtilis, saccharomyces cerevisiae, lactobacillus fermentum, lactobacillus rhamnosus and lactobacillus plantarum), centrifuging for 2 minutes at 12000rpm, discarding the supernatant, adding 60 mu L of TE Buffer, boiling for 2 minutes at 100 ℃, centrifuging for 1 minute at 8000rpm after cooling, and carefully sucking the supernatant to obtain genome DNA of the fermentation strain (bacillus subtilis, saccharomyces cerevisiae, lactobacillus fermentum, lactobacillus rhamnosus and lactobacillus plantarum).
B. Standard curve construction:
1. bacillus subtilis: PCR amplification of the Bacillus subtilis genomic DNA with specific primer pair (upstream primer F: CGTAGAGCCACTTGAGCG, downstream primer R: CTGCCGTTACAGTTCCTT), gel cutting, recovering, and diluting to 1×10 2 ~1×10 9 Copy/. Mu.L was used as a standard for fluorescent quantitative PCR reactions. Converting the measured DNA concentration of the standard product into copy number, and generating a bacillus subtilis standard curve by taking the logarithmic value of the copy number as an abscissa and the corresponding Ct value as an ordinate;
the copy number calculation formula is as follows: copy number = DNA concentration (ng/. Mu.l). Times.10 -9 ×6.023×10 23 /(660×base number);
the standard curve fitting equation of the bacillus subtilis is Y= -3.4359X+34.363;
2. Saccharomyces cerevisiae: PCR amplification of Saccharomyces cerevisiae genome DNA with specific primer pair (upstream primer F: GCGATAACGAACGAGACCCTAA and downstream primer R: CCAGCACGACGGAGTTTCACAAGAT), cutting, recovering, and diluting to 1×10 2 ~1×10 9 Copy/. Mu.L was used as a standard for fluorescent quantitative PCR reactions. Converting the measured DNA concentration of the standard product into copy number, and generating a saccharomyces cerevisiae standard curve by taking the logarithmic value of the copy number as an abscissa and the corresponding Ct value as an ordinate;
the copy number calculation formula is as follows: copy number = DNA concentration (ng/. Mu.l). Times.10 -9 ×6.023×10 23 /(660×base number);
the standard curve fitting equation of the saccharomyces cerevisiae is Y= -3.4868X+39.322;
3. lactobacillus fermentum: PCR amplification of the genome DNA of Lactobacillus fermentum with specific primer pair (upstream primer F: CCTGATTGATTTTGGTCGCCAAC and downstream primer R: ACGTATGAACAGTTACTCTCATACGT), cutting, recovering, and diluting to 1×10 2 ~1×10 9 Copy/. Mu.L, and performing fluorescent quantitative PCR reaction as a standard. Converting the measured DNA concentration of the standard product into copy number, and generating a lactobacillus fermentum standard curve by taking the logarithmic value of the copy number as an abscissa and the corresponding Ct value as an ordinate;
the copy number calculation formula is as follows: copy number = DNA concentration (ng/. Mu.l). Times.10 -9 ×6.023×10 23 /(660×base number);
the standard curve fitting equation of the lactobacillus fermentum is Y= -3.8953X+38.279;
4. lactobacillus plantarum: performing PCR amplification on lactobacillus plantarum genome DNA with a specific primer pair (upstream primer F: GTGGTGCGGTCGATATTTTAGTT and downstream primer R: TCAGCCGCGCTTGTAACC), cutting gel, recovering, and diluting to 1×10 2 ~1×10 9 Copy/. Mu.L was used as a standard for fluorescent quantitative PCR reactions. Converting the measured DNA concentration of the standard product into copy number, and generating a lactobacillus plantarum standard curve by taking the logarithmic value of the copy number as an abscissa and the corresponding Ct value as an ordinate;
the copy number calculation formula is as follows: copy number = DNA concentration (ng/. Mu.l). Times.10 -9 ×6.023×10 23 /(660×base number);
the standard curve fitting equation of the lactobacillus plantarum is Y= -3.3338X+33.904;
5. lactobacillus rhamnosus: carrying out PCR amplification on lactobacillus rhamnosus genome DNA by using a specific primer pair (an upstream primer F: GACGCAGCCGGTTGACCCAA and a downstream primer R: GGCGGCAGTTGCCCCAGAAT), cutting gel, recovering the obtained PCR product, and diluting to 1X 10 2 ~1×10 9 Copy/. Mu.L was used as a standard for fluorescent quantitative PCR reactions. Converting the measured DNA concentration of the standard product into copy number, and generating a lactobacillus rhamnosus standard curve by taking the logarithmic value of the copy number as an abscissa and the corresponding Ct value as an ordinate; y= -3.1942x+32.687
The copy number calculation formula is as follows: copy number = DNA concentration (ng/. Mu.l). Times.10 -9 ×6.023×10 23 /(660×base number);
the standard curve fitting equation of the lactobacillus rhamnosus is Y= -3.1942X+32.687;
C. extracting DNA of a feed sample: accurately weighing 1g of the fermented feed additive obtained in the step (4), adding 10mL of PBS Buffer solution, oscillating for 20 minutes, filtering with 8 layers of gauze, taking 1mL of filtrate, centrifuging at 12000rpm for 2 minutes, discarding the supernatant, adding 60 mu L of TE Buffer, boiling at 100 ℃ for 2 minutes, centrifuging at 8000rpm for 1 minute after cooling, and carefully sucking the supernatant to obtain a feed sample DNA template;
D. fluorescent quantitative PCR detection: amplification and analysis were performed using Quantum studio 3Real-Time PCR System (Applied Biosystems). The fluorescent quantitative PCR reaction system is as follows: SYBR Green Premix Ex Taq 10. Mu.L, rox Reference Dye 0.4.4. Mu.L, 0.8. Mu.L each for the upstream and downstream primers, 2. Mu.L for the DNA template, and 6. Mu.L for ddH 2O. Fluorescent quantitative PCR reaction conditions: pre-denaturation at 95 ℃ for 30s, amplification at 95 ℃ for 5s and amplification at 60 ℃ for 30s for 40 cycles, then melting curve analysis is carried out, and the Ct value obtained calculates the number of fermentation strains according to a standard curve.
I, change of bacterial quantity of bacillus subtilis under different traditional Chinese medicine adding proportion
Under different traditional Chinese medicine adding ratios, the bacterial load change of the bacillus subtilis in the fermentation process is shown in figure 4. It is clearly observed. In the fermented traditional Chinese medicine feed with the addition amount of 0% and 10% of traditional Chinese medicines, when the addition mass ratio of the compound traditional Chinese medicine premix is 0% and 10%, the bacterial amount of bacillus subtilis is in a descending trend, but the bacterial amount of 10% is higher than 0%; in other groups of Chinese medicinal additive groups, the bacterial load is rapidly increased at the beginning, and the bacterial load reaches the maximum at the time of fermentation for 1d, and then starts to decrease and tends to be at the temperature. Wherein 50%, 70%, 90% of the groups are eventually maintained at a higher bacterial load. At 7d, the amount of the group bacteria added in the feed is still maintained at a higher level of 1.44×10 6 copies/g, 0% group bacteria-2.37 x 10 4 60.76 times the copies/g.
Experimental results show that the addition of the compound traditional Chinese medicine in the formula is beneficial to the growth of bacillus subtilis, but is not as much as possible. When the addition amount of the traditional Chinese medicine is below 70%, the larger the addition amount of the traditional Chinese medicine is, the more obvious the gain effect is; however, if the gain exceeds 70%, the gain effect is reduced.
Saccharomyces cerevisiae with variation of bacterial amount under different traditional Chinese medicine adding proportion
Different traditional Chinese medicinesThe bacterial amount of Saccharomyces cerevisiae in the fermentation process is shown in FIG. 5 at the addition ratio. The bacterial variation trend of each traditional Chinese medicine adding group is approximately the same. As the fermentation proceeds, the amount of Saccharomyces cerevisiae increases, reaches a maximum at 1d of fermentation, and then decreases continuously. However, it is obviously observed that the addition of the traditional Chinese medicine is beneficial to the growth of saccharomycetes. During fermentation for 1d, it is obviously observed that the maximum bacterial load of 50% of the traditional Chinese medicine adding groups is 1.57 x 10 9 The copies/g is 4.63 x 10 than 0% of the traditional Chinese medicine addition group 7 The quantity of the cobies/g bacteria is improved by about 33.91 times. On the 7 th day of fermentation, the maximum amount of Saccharomyces cerevisiae in 70% of the Chinese medicinal additive groups is 6.62×10 7 The copies/g is about 1.54 x 10 of 0% of the traditional Chinese medicine addition group 6 42.99 times the copies/g.
III, variation of bacterial amount of Lactobacillus fermentum in different Chinese medicine adding proportion
The bacterial amount change of lactobacillus fermentum in the fermentation process is shown in figure 6 under different traditional Chinese medicine adding proportion. The bacteria amount change trend of the lactobacillus fermentum added with the traditional Chinese medicines in different groups is approximately the same, and the bacteria amount reaches the maximum when the bacteria amount is 1d, and then gradually decreases. Wherein the bacterial content of the 10% traditional Chinese medicine adding group approaches to 0% in the first 5d fermentation, but the bacterial content of the 10% traditional Chinese medicine adding group is slightly less than 0% in the 7d fermentation. From the experimental results, it can be inferred that the addition of a small amount of the traditional Chinese medicine (10%) had no much effect on the growth of lactobacillus fermentum. The addition of a large amount of traditional Chinese medicines can inhibit the growth of lactobacillus fermentum. However, the inhibition effect is not very strong, and the composition still has higher viable count of 10% in the groups of 50% and 70% of Chinese medicine addition 7 Orders of magnitude, respectively, 3.20 x 10 7 copies/g、1.04*10 7 copies/g。
IV, change of the bacterial load of the lactobacillus plantarum under different traditional Chinese medicine adding ratios
The bacterial load change of lactobacillus plantarum in the fermentation process under different traditional Chinese medicine adding ratios is shown in figure 7. In samples with different traditional Chinese medicine addition ratios, the bacteria amount change trend of the lactobacillus plantarum is approximately the same, and the bacteria amount reaches the maximum at the 1 st day of fermentation, and then gradually decreases. The experiment result shows that the Chinese medicine with certain concentration is added to lactobacillus plantarum Is beneficial for growth. On the 7 th day of fermentation, in the range of 0% -50% of the traditional Chinese medicine addition amount, the bacterial amount of the lactobacillus plantarum is increased along with the increase of the traditional Chinese medicine addition amount, and the maximum bacterial amount of the lactobacillus plantarum in the group added by 50% of the traditional Chinese medicines is 3.59 x 10 8 The copies/g is 0% of the Chinese medicine added group bacterial amount-7.47 x 10 7 4.80 times the copies/g. The addition of high concentration Chinese medicine is detrimental to the growth of lactobacillus plantarum, for example, the bacterial load of 100% Chinese medicine addition group is only 7.44×10 6 The copies/g is only 2.07% of the Chinese medicine added group bacteria amount.
V. variation of the bacterial load of Lactobacillus rhamnosus in different Chinese medicine addition ratios
The bacterial amount change of lactobacillus rhamnosus in the fermentation process is shown in figure 8 under different traditional Chinese medicine adding ratios. The lactobacillus plantarum has similar tendency of changing the bacterial load in samples with different traditional Chinese medicine adding ratios, and reaches the maximum bacterial load at the 1 st day of fermentation, and then gradually decreases. According to the experimental results, it can be obviously observed that the bacterial load is increased along with the addition of the traditional Chinese medicine in 0% -10% group. When the addition amount of the traditional Chinese medicine is 30%, the maximum bacterial amount is 2.23 x 10 6 The copies/g is 4.64 times 10 than 0% of the traditional Chinese medicine addition group 5 The bacterial count of the cobies/g is improved by 4.81 times. At the 7 th day of fermentation, the highest lactobacillus rhamnosus bacterial load of 50% of traditional Chinese medicine addition groups is 3.47×10 5 The copies/g is 0% of the added group bacterial amount of the traditional Chinese medicine-7.27 x 10 4 4.77 times the copies/g. The result shows that the addition of low-content traditional Chinese medicine is beneficial to the growth of lactobacillus rhamnosus, but when the content of the traditional Chinese medicine is too high, the growth of lactobacillus rhamnosus is inhibited.
According to the microbial inoculum size results of each fungus in different traditional Chinese medicine adding ratios, the traditional Chinese medicine adding ratio of 50% is comprehensively considered and selected as the traditional Chinese medicine adding ratio for subsequent experiments. Under the traditional Chinese medicine adding proportion, each fermentation strain has better growth, and the adding amount of the traditional Chinese medicine is not too low to influence the action effect of the medicinal components.
The invention has the beneficial effects that:
(1) The invention creatively researches the antibacterial traditional Chinese medicine of pathogenic bacteria aeromonas hydrophila, fermentation strains, enzymes, the addition proportion of traditional Chinese medicines and auxiliary materials and the growth relation of fermentation strains, and obtains the optimal addition proportion of traditional Chinese medicines, fermentation conditions and fermentation process. Finally, the fermented traditional Chinese medicine additive developed by the invention is used for cultivating the Chinese soft-shelled turtles, can effectively improve the immune function, intestinal digestion level and the like of the Chinese soft-shelled turtles in long-term feeding, and can effectively improve the survival rate of young Chinese soft-shelled turtles in short-term aeromonas hydrophila toxicity attack experiments. The fermented traditional Chinese medicine can be used as a high-quality feed additive for aquaculture, and has remarkable control effect on aeromonas hydrophila.
(2) The invention researches proper traditional Chinese medicine addition amount by changing the flora change of the fermentation strain measured by different traditional Chinese medicine addition ratios, and carries out fermentation treatment on the compound traditional Chinese medicine, so that the medicinal effect components of the compound traditional Chinese medicine are improved or converted into other medicinal effect components which are easy to absorb, and the feed additive is rich in probiotics, can effectively improve the immunity of cultured animals, has acid fragrance and certain antibacterial effect, and is convenient to store.
Drawings
FIG. 1 is a high performance liquid chromatogram of six active ingredients; wherein 1, chlorogenic acid; 2. ferulic acid; 3. baicalin; 4. quercetin; 5. luteolin; 6. baicalein;
FIG. 2 is a high performance liquid chromatogram of gallic acid;
FIG. 3 is a primer specificity verification of fermentation broth; wherein (a) bacillus subtilis primer specificity verification; (b) Saccharomyces cerevisiae primer specificity verification; (c) lactobacillus fermentum primer specificity verification; (d) lactobacillus plantarum primer specificity verification; (e) lactobacillus rhamnosus primer specificity verification;
m: DNA Marker (50-500 bp); 1: bacillus subtilis; 2: saccharomyces cerevisiae; 3: fermenting lactobacillus; 4: lactobacillus plantarum; 5: lactobacillus rhamnosus;
FIG. 4 shows the change of the bacterial load of the bacillus subtilis in different traditional Chinese medicine adding ratios in the fermentation process;
FIG. 5 shows the change of the amount of Saccharomyces cerevisiae at different ratios of traditional Chinese medicine addition during fermentation;
FIG. 6 shows the variation of the bacterial load of Lactobacillus fermentum at different traditional Chinese medicine addition ratios in the fermentation process;
FIG. 7 shows the change of the bacterial load of Lactobacillus plantarum in different traditional Chinese medicine adding ratios in the fermentation process;
FIG. 8 shows the variation of the bacterial load of Lactobacillus rhamnosus with different Chinese medicinal addition ratios during fermentation;
FIG. 9 is a response surface and contour plot of interaction factors; (a) The response surface of the interaction factor (b) the contour of the interaction factor;
FIG. 10 shows the total phenol content after fermenting the Chinese medicine in different strain addition ratios;
FIG. 11 shows the total phenol content after fermenting the Chinese medicine with different enzyme addition ratios;
FIG. 12 is a graph showing the effect of inoculum size on total phenol content;
FIG. 13 is a graph showing the effect of enzyme addition on total phenol content;
FIG. 14 is a graph showing the effect of fermentation temperature on total phenol content;
FIG. 15 is a graph showing the effect of moisture content on total phenol content;
FIG. 16 is a graph of the effect of fermentation time on total phenol content;
FIG. 17 is a response surface 3D plot (a) and contour plot (b) of fermentation time and moisture content effect on total phenol content;
FIG. 18 is a response surface 3D plot (a) and contour plot (b) of the effect of enzyme addition and fermentation time on total phenol content;
FIG. 19 is a response surface 3D plot (a) and a contour plot (b) of the effect of enzyme addition and moisture content on total phenol content;
FIG. 20 is a paraffin section of the intestinal tract of a Chinese soft shell turtle; wherein (a) and (c) are experimental groups; (b) and (d) are control groups.
Detailed description of the preferred embodiments
The invention is further described below in connection with specific embodiments.
The laccase used in the invention is purchased from Shandong Su Kehan biotechnology Co., ltd, and the enzyme activity is 10000U/g. Acid cellulase, xylanase, mannase and tannase are all purchased from Yu Xiacheng (Beijing) biotechnology development Co., ltd, and the enzyme activities are 10000U/g. Beta-glucanase was purchased from Yu Xiacheng (Beijing) biotechnology development Co., ltd, and the enzyme activity was 50000U/g.
Strain sources: bacillus I: bacillus subtilis (Bacillus subtilis) CGMCC1.921; II Yeast: saccharomyces cerevisiae (Saccharomyces cerevisiae) CGMCC2.1527; III lactic acid bacteria: lactobacillus fermentum (Lactobacillus fermentum) CGMCC 1.15608, lactobacillus rhamnosus (Lactobacillus rhamnosus) CGMCC 1.577 and lactobacillus plantarum (Lactobacillus plantarum).
Example 1:
(1) Activation culture of bacillus, saccharomycetes and lactic acid bacteria:
A. firstly, preparing a culture medium of bacillus, saccharomycetes and lactobacillus;
bacillus liquid and solid media: 10g of tryptone, 10g of sodium chloride, 5g of yeast powder, 1L of distilled water, natural pH, sterilization at 121 ℃ for 20min, and the components of the bacillus solid culture medium are the same as those of the liquid culture medium; except that 15g of agar was added.
Yeast liquid and solid medium: filtering with 8 layers of gauze after 200g of potato is boiled and soft, filtering with 20g of glucose, 3g of potassium dihydrogen phosphate, 1.5g of magnesium sulfate, fixing the volume to 1L with distilled water, naturally sterilizing at 121 ℃ for 20min; the components of the saccharomycete solid culture medium are the same as those of the liquid culture medium, except that 15g of agar is added;
lactic acid bacteria liquid and solid medium: 10g of beef extract, 10g of tryptone, 20g of glucose, 5g of yeast powder, 2g of dipotassium hydrogen phosphate, 2g of diammonium hydrogen citrate, 5g of anhydrous sodium acetate, 1mL of Tween 80, 0.58g of magnesium sulfate, 0.25g of manganese sulfate, 1L of distilled water, pH7.2 and sterilizing at 121 ℃ for 20min; the components of the lactobacillus solid culture medium are the same as those of the liquid culture medium, except that 15g of agar is added;
B. the method for activating and culturing bacillus, saccharomycetes and lactobacillus comprises the following steps:
culturing bacillus liquid strain: inoculating glycerol bacteria preserved at-80deg.C to bacillus solid culture medium, culturing at 30deg.C for 18 hr for resuscitating strain, selecting single colony, inoculating into shake flask (250 mL) containing 100mL bacillus liquid culture medium, culturing at 180r/min at 30deg.C for 12 hr to obtain bacillus fermentation seed liquid; inoculating 2% (v/v, namely inoculating 2mL of fermentation seed liquid to each 100mL of liquid culture medium) according to actual needs to the liquid culture medium for expansion culture; the bacillus is bacillus subtilis CGMCC1.921.
Culturing yeast liquid strain: inoculating glycerol bacteria preserved at-80deg.C to yeast solid culture medium, culturing at 28deg.C for 20 hr to recover strain, then picking single colony, inoculating into shake flask (250 mL) containing 100mL yeast liquid culture medium, culturing at 180r/min at 28deg.C for 12 hr to obtain yeast fermentation seed liquid; inoculating 2% (v/v, namely inoculating 2mL of fermentation seed liquid to each 100mL of liquid culture medium) according to actual needs to the liquid culture medium for expansion culture; the microzyme is Saccharomyces cerevisiae CGMCC 2.1527.
Culturing lactobacillus liquid strain: inoculating glycerol bacteria preserved at-80 ℃ to a lactobacillus solid culture medium respectively under aseptic conditions, culturing for 24 hours at 37 ℃ to recover strains, picking single bacterial colonies, inoculating the single bacterial colonies into an anaerobic bottle (50 mL) filled with 50mL of lactobacillus liquid culture medium, standing for 18 hours at 37 ℃ to obtain lactobacillus fermentation seed liquid, and inoculating 2% (v/v) of the lactobacillus fermentation seed liquid into the liquid culture medium according to the actual requirement in an inoculum size of 2mL of fermentation seed liquid inoculated per 100mL of liquid culture medium for expanded culture; the lactobacillus is Lactobacillus plantarum CGMCC1.557, lactobacillus fermentum CGMCC1.15608, and Lactobacillus rhamnosus CGMCC1.577.
(2) Preparing an anaerobic fermentation culture medium, wherein the anaerobic fermentation culture medium comprises the following components in percentage by weight: the anaerobic fermentation medium is obtained by uniformly mixing the compound traditional Chinese medicines (20% of baical skullcap root, 12% of Chinese gall, 14% of wild chrysanthemum, 4% of humifuse euphorbia herb), 30% of bean pulp, 20% of secondary powder and 1% of compound enzyme.
(3) Inoculating the bacillus subtilis fermentation seed liquid, the saccharomyces cerevisiae fermentation seed liquid, the lactobacillus plantarum fermentation seed liquid, the lactobacillus fermentum fermentation seed liquid and the lactobacillus rhamnosus fermentation seed liquid which are subjected to the activation culture in the step (1) into the fermentation culture medium in the step (2), wherein the total inoculation amount is 2% (v/m, namely 2mL:100 g) of the weight of the fermentation culture medium, the adding ratio of each seed liquid is (the volume ratio of lactobacillus to bacillus to saccharomycetes=2:2:3), and the total number of viable bacteria of the lactobacillus fermentation seed liquid is 1.5x10 8 ~3.5×10 9 cfu/mL; the total number of viable bacteria of the bacillus and the saccharomycetes is 1.0×10 8 ~2.8×10 9 cfu/mL; the yeast fermentation seed liquid is Saccharomyces cerevisiae fermentation seed liquid, and the total number of viable bacteria in the lactobacillus fermentation seed liquid is 1.5X10 8 ~3.5×10 9 cfu/mL. Uniformly mixing, and adjusting the water content to 45% to obtain an anaerobic fermentation mixture; anaerobic fermentation is carried out in a fermentation bag under the sealing condition, the fermentation temperature is 30 ℃, and the finished product is obtained after 7 days of fermentation, namely the compound fermented traditional Chinese medicine feed additive.
Example 2: optimization of formula of fermented traditional Chinese medicine feed additive
The formula is optimized by using the D-optimal mixture Design in Design-Expert for radix scutellariae, chinese gall, wild chrysanthemum and humifuse euphorbia herb, and a group of compound traditional Chinese medicine formulas for effectively inhibiting aeromonas hydrophila are obtained by taking the minimum inhibitory concentration of different aeromonas hydrophila as the response.
The method for measuring the minimum inhibitory concentration comprises the following steps: in an ultra clean bench, 100 μl of liquid nutrient agar medium was added to one row in a 96-well plate. Adding 50 mu L of the traditional Chinese medicine extract into a first hole for uniform mixing, then adding 50 mu L of the solution in the first hole into a second hole for uniform mixing, then adding 50 mu L of the solution in the second hole into a third hole for uniform mixing, and so on. After mixing the last well, 50. Mu.L of the solution was aspirated and discarded. Finally, 50. Mu.L of the pathogenic bacteria liquid cultured to the logarithmic phase pair was added to each well. 60% methanol was used as a negative control, kanamycin at a concentration of 0.2mg/mL was used as an antibiotic positive control, and a nutrient agar well without bacteria solution was used as a blank control. And (3) placing the 96-well plate in a 37 ℃ incubator for culturing for 24 hours, then observing the growth condition of the 96-well plate, and visually observing to obtain the transparent sterile growth concentration, namely the minimum antibacterial concentration.
The formula design and the results are shown in table 6, table 7 lists the test results of the minimum inhibitory concentration of aeromonas hydrophila after the fermentation of the baikal skullcap root, the humifuse euphorbia herb, the gallnut and the wild chrysanthemum in different proportions, A, B, C, D in the table are the mass fractions of the baikal skullcap root, the humifuse euphorbia herb, the gallnut and the wild chrysanthemum respectively, and the test values of the response values are subjected to secondary multiple regression fitting by using software to establish a regression model as follows:
Y=10.72A+20.73B+92.64C+21.63D-1.82AB-165.49AC+16.30AD-204.57BC+84.86BD-182.92CD-2305.77ABC+2892.73ABD-485.90ACD+262.30BCD R2=0.9950 P<0.0001
TABLE 6 experimental factors and levels
TABLE 7D-optimal design and test results
Table 8 analysis of variance of regression equation
The multivariate correlation coefficient R2=0.995 and the correction decision coefficient R2Adj= 0.9842 show that the model fits well to the actual situation, the fitting model and the mixed linear model P are less than 0.0001, the model selected by the test has high significance, the mismatching term is not significant at the level of P=0.05, so the fitting degree of the model is good, and the formula of the compound traditional Chinese medicine can be determined by using the model.
And (3) drawing contour lines and response surface analysis of interaction factors of the baikal skullcap root, the humifuse euphorbia herb and the gallnut according to the experimental result of the D-mixing design and a regression equation, and as shown in fig. 9, the response surface diagram is a curved surface, which shows that the three have certain interaction. The range of variation of each factor was set by the optimization function of the software, and the expected response values were set as shown in table 9.
The software data analysis gives several combinations that meet or approach the target response value and provides a predicted value. The method selects 40% of baical skullcap root, 8% of humifuse euphorbia herb, 22.94% of Chinese gall and 29.06% of wild chrysanthemum flower as a compound traditional Chinese medicine formula, and predicts the minimum inhibitory concentration response value of the wild chrysanthemum flower to aeromonas hydrophila to 4.5903mg/mL after fermentation. The optimized combined baikal skullcap root 40%, humifuse euphorbia herb 8%, chinese gall 24% and wild chrysanthemum flower 28% are adopted, the minimum antibacterial concentration actual value of the fermented formula for aeromonas hydrophila is 4.6517mg/mL, no obvious difference (P is more than 0.05) from the predicted value is the minimum value in all experiments, and therefore the formula is selected as a compound fermented traditional Chinese medicine formula.
Table 9 analysis of variance of regression equation
Example 3: determination of optimum strain addition ratio
According to the experimental result, selecting the strain which can effectively promote the medicinal components after single-strain fermentation as the fermentation strain. Fermenting with different strain adding ratios, controlling other fermentation conditions to be the same, and exploring the influence of the fermentation on total polyphenol before and after fermentation. Wherein 9 groups are set, and the volume ratio of the lactobacillus fermentation seed liquid, the bacillus fermentation seed liquid and the saccharomycete fermentation seed liquid is respectively 1:1: 1. 1:2: 2. 1:3: 3. 2:1: 2. 2:2: 3. 2:3: 1. 3:1: 3. 3:2:1 and 3:2:3. in a solid state fermentation system, lactic acid bacteria, bacillus and saccharomycetes are used for fermentation in a synergistic way. The aerobic growth of the bacillus subtilis consumes residual oxygen in the sealed bag, and the abundant enzyme system is produced to decompose and utilize macromolecular substances in the fermented traditional Chinese medicine feed additive. The saccharomyces cerevisiae consumes oxygen through aerobic respiration, and simultaneously, the saccharomyces cerevisiae grows to produce enzyme to promote the decomposition and utilization of macromolecular substances in a fermentation matrix. In addition, the saccharomyces cerevisiae can also produce amino acid, vitamin and other nutrient substances, and can promote the growth and proliferation of lactobacillus. The bacillus and the saccharomycete consume oxygen in the early fermentation period, and the anaerobic environment can promote the growth of lactic acid bacteria. Besides the capability of producing organic acid, lactic acid bacteria are rich in enzyme systems, and can degrade macromolecular substances to generate micromolecular substances such as monosaccharide, amino acid and the like. Yeast can also utilize monosaccharide to meet the requirement of self-growth and proliferation. Therefore, the interaction among the fermentation strains is very tight, and a proper strain proportion needs to be found, so that the release of the effective components of the traditional Chinese medicine can be effectively improved under the proportion. The experimental results are shown in fig. 10, when lactic acid bacteria: bacillus subtilis: saccharomyces cerevisiae is 2:2:3, the total phenol content is up to 37.69mg/g.
Example 4: determination of the optimal enzyme addition ratio
Wherein 9 groups of cellulase, hemicellulase and tannase are set, and the mass ratio of the cellulase to the hemicellulase to the tannase is respectively 1:1: 1. 1:2: 2. 1:3: 3. 2:1: 2. 2:2: 3. 2:3: 1. 3:1: 3. 3:2:1 and 3:2:3. the research shows that the cellulase, the hemicellulase and the tannase have synergistic effect, and the different structures of the cellulase and the hemicellulase acting on plants can degrade lignocellulose more efficiently, so that the effective components are easier to release, and the intracellular plant tannin is easier to combine with the tannase. Tannase hydrolyzes vegetable tannins to produce small molecular phenolic acids which are more readily available to the body. Therefore, a proper enzyme adding proportion needs to be found, the experimental result is shown in fig. 11, and cellulase is selected: hemicellulase: tannase is 2:2:3, at which the total phenol content was the highest, was 41.25mg/g.
Example 5: optimization of fermentation conditions
(1) Single factor optimization of fermentation conditions
1. Effect of inoculum size on fermented traditional Chinese medicine
Weighing 1000g of traditional Chinese medicine (400 g of baical skullcap root, 240g of Chinese gall, 280g of wild chrysanthemum flower and 80g of humifuse euphorbia herb), 600g of bean pulp and 400g of powder, uniformly mixing, and equally dividing the mixture into 20 parts, wherein 50g of each part is used as a fermentation substrate.
And 7 groups of fermentation matrixes are selected in each group, and fermentation bacterial liquids with different inoculation amount ratios are respectively added by taking the mass of the fermentation matrixes as a reference, wherein the fermentation bacterial liquids are respectively 0%, 0.5%, 1%, 2%, 4%, 8% and 16% (V/W). Distilled water is added to control the water content of each group to be 50%, and 1% (W/W) of a fermentation enzyme preparation is added; and (3) carrying out packed anaerobic fermentation at the fermentation temperature of 30 ℃ for 7 days. Experiments were performed in 3 replicates, averaged, and repeated 3 times, as follows.
In the process of the synergistic fermentation of the bacterial enzymes, the fermentation strain often plays an important role. The fermentation strain utilizes the nutrient substances in the traditional Chinese medicine feed, and the metabolism generates various secondary metabolites such as lignocellulose, tannase and the like, so that the release of the medicinal components is promoted, and the total phenol amount is increased. As shown in FIG. 12, the total phenol content in the fermented chinese herbal feed was the highest at an inoculum size of 2% (V/W), which was 42.27mg/g. At smaller inoculum sizes, the initial number of fermenting microorganisms is smaller, and enzymes etc. secreted by metabolism are smaller, so that the total phenol content is lower. When the inoculation amount is large, the microorganism amount in the matrix is large, so that a large amount of nutrient substances are consumed in early fermentation so as to meet the requirement of self-growth, and the growth is inhibited due to insufficient nutrient substances. In addition, the high inoculation amount can lead to rapid decrease of the pH value in the feed when rich organic acid is produced during fermentation, and the too low pH value can inhibit the growth of fermentation strains and enzyme production. Therefore, the amount of the selected inoculum was 2% (V/W).
2. Influence of the addition of the fermentation enzyme on the fermented Chinese medicine
According to the above experiment, the inoculation amount was selected to be 2% (V/W), and other fermentation conditions were unchanged, and the addition amounts of the different enzyme preparations were changed to be 0%, 0.05%, 0.1%, 0.5%, 1%, 2%, and 4% (W/W), respectively.
As shown in FIG. 13, the addition amount of the enzyme has an important effect on the total phenol content in the fermented traditional Chinese medicine, which increases with the increase of the enzyme, but the increase of the total phenol is slowed down after the addition amount of 1%. This may be due to the addition of enzymes which help hydrolyze plant cell wall components and allow intracellular polyphenols to be more readily released from the cell. When the enzyme addition amount was 4%, the amount was slightly lower than that of the first two groups. The reason for this may be that the amount of substrate is constant and the amount of enzyme has reached saturation, so there is not so significant gain in the increase of total phenol. And the addition amount of the enzyme is too high, so that the traditional Chinese medicine ratio in each gram of fermented traditional Chinese medicine additive is reduced, and the total phenol content in each gram of fermented traditional Chinese medicine additive is reduced.
Although the total phenol content was the highest at an enzyme addition of 2%, it was 43.21mg/g. However, considering the 1% enzyme added group, its total phenol content was not much different from that of the 2% group, 42.89mg/g. For economic reasons, an addition of 1% is chosen.
3. Influence of fermentation temperature on fermented Chinese medicine
According to the above experiment, the enzyme addition amount was 1% (W/W), other fermentation conditions were not changed, and the fermentation temperatures were changed to 20 ℃, 25 ℃, 30 ℃, 35 ℃ and 40 ℃, respectively.
The experimental results are shown in FIG. 14, and it is known that the fermentation temperature plays a very important role in the fermentation process. In the range of 20 ℃ to 30 ℃, the total phenol is increased with the increase of temperature. Highest at 30 ℃, 43.02mg/g. However, after 30 ℃, the polyphenol content thereof showed a tendency to decrease. The possible reasons for this are that the yeast plays a relatively important role in the fermentation process, the optimum growth temperature of Saccharomyces cerevisiae is between 25 ℃ and 30 ℃, and the strain gradually decays above 30 ℃. The optimal growth temperature of lactobacillus is between 30 ℃ and 40 ℃, and the optimal temperature of bacillus is between 30 ℃ and 37 ℃.
In the fermentation temperature environment of 30 ℃, each fermentation strain can grow well. This temperature can thus be chosen as the optimum fermentation temperature.
4. Influence of different water contents on fermented traditional Chinese medicine
According to the above experiment, the fermentation temperature was selected to be 30 ℃, and other fermentation conditions were unchanged, and the water contents were changed to be 30%, 40%, 50%, 60%, 70%, 80% (V/W), respectively.
The experimental results are shown in fig. 15, which shows that the total phenol content increases with increasing water content. Water is important in the fermentation process, and water is required for the growth, proliferation and enzyme production of fermentation strains. As the water content increases, its total phenol content increases. The reason for the speculation is: the water content in the feed is increased, the free water content in the feed is increased, and the active growth of the strain is more suitable, so that the fermentation flora of the strain is better grown. The reason is as follows: the water content in the feed is increased, and the water-soluble total phenols in the traditional Chinese medicinal materials are easier to dissolve and release. Thus the total phenol content is increased. However, when the water content is too high, other harmful bacteria proliferate in the fermentation strain, and the fermentation strain is deteriorated, so that the fermentation strain is not easy to preserve. At 60d of fermentation, some mould was observed in the feeds of the group with a water content of 70%, 80%. Therefore, the water content was selected to be 50%.
5. The influence of different fermentation time on the fermented traditional Chinese medicine is explored
According to the above experiment, the fermentation water content was selected to be 50% (V/W), other fermentation conditions were not changed, and different fermentation times were changed to be 0d, 1d, 3d, 5d, 7d, 9d, 14d, 28d, respectively.
The Chinese medicinal feed undergoes a series of material changes during fermentation, such as growth and proliferation of fermentation strain, and metabolic conversion of material. The process needs a certain time, but the fermentation time is prolonged, so that better fermentation effect can not be achieved, and the problems of utilization of medicinal components, pollution of harmful bacteria, increase of fermentation cost and the like can be caused.
As shown in FIG. 16, the total phenol content increased with the increase in fermentation time at 1 to 7 days of fermentation. However, after 7 days, the total phenol content in the fermented traditional Chinese medicine feed is reduced. The possible reasons for this are that in the initial fermentation stage, the fermentation strain first absorbs and utilizes nutrients such as easily-decomposed soybean meal and secondary powder for self-growth and proliferation. Along with the proliferation of the fermentation strain, the metabolism of the strain generates components which can be decomposed in Chinese herbal medicines and are difficult to decompose, such as lignocellulose, tannase and the like. And the lactic acid bacteria produce organic acids to provide a more acidic environment (pH about 4.0 to 5.0) for the feed, which is more suitable for the action of lignocellulose. Thus, the total phenol content gradually increases in the early stage. However, in the latter fermentation stage, since a large amount of fermentation strains exist, substances such as easily digestible soybean meal and secondary powder are utilized, and thus the fermentation flora starts to utilize the total polyphenol to satisfy the growth of the fermentation flora. In summary, a suitable fermentation time of 7 days was chosen.
(2) Response surface optimization fermentation conditions
According to the previous experimental results, the fermentation time, the water content and the enzyme addition amount are selected as influencing factors by taking the total phenol content as an index for research. The Design of experiments and optimization were performed using the Box-Behnken Design (BBD) of Design Expert 8.0.6 software. The experimental factors and levels are shown in Table 10.
Table 10 experimental factors and levels
According to the results of the experiment, the response surface optimization experiment is designed by using the total phenol content as a response value, the fermentation time, the water content and the enzyme addition amount as independent variables and adopting a Box-Behnken Design (BBD) of Design Expert 8.0.6. The experimental protocol and results are shown in table 11.
TABLE 11 response surface Experimental design and results
Performing multiple regression fitting on the data to obtain a quadratic polynomial model equation between A (fermentation time), B (water content), C (enzyme addition ratio) and the total phenol content (X) in the fermented traditional Chinese medicine feed:
X=+38.89+1.26*A-1.35*B+1.70*C+1.28*A*B-0.31*A*C-0.72*B*C-0.084*A2+2.71*B2+0.060*C2
analysis of variance is shown in Table 12. The response surface regression model is remarkable (P is less than 0.05), which shows that the total phenol content is remarkably different under different conditions. The mismatching term is not obvious (0.0521 is more than 0.05), which shows that the model can better describe the relationship between different fermentation conditions and the total phenol content in the compound traditional Chinese medicine feed additive. A coefficient of variation of 2.52 less than 5% indicates that the model is repeatable. The R2 and Adj R2 of the model are 0.9266 and 0.8232 respectively, which show that the fitting degree is good, the error is small, and the regression equation can simulate the influence of the actual experimental point on the increase of the total phenol content. Adeq precision is greater than 4.0, and the model meets the prediction requirements.
In the model established in the experiment, A, B, C, B2 has very remarkable influence on the total phenol content of the fermented traditional Chinese medicine (P is less than 0.01), and AB has remarkable influence on the total phenol content of the fermented traditional Chinese medicine (P is less than 0.05).
Table 12 analysis of variance of regression model
C.V.%2.52;R 2 =0.9266;Adj R 2 =0.8323;Pred R 2 =0.8589;Adeq precision=12.673
The steeper the response surface 3D plot shown in figures 17, 18, 19, the greater the effect of this factor on the response value, the denser the contour lines, the stronger the interaction, as shown in figures 17, 19, the more elliptical, indicating that the interaction of fermentation time and moisture content, enzyme addition and moisture content have a significant effect on total phenol content, as well as the response surface 3D plot.
Predicting the optimal fermentation process of the response surface model: the fermentation time is 7 days, the water content of the compound traditional Chinese medicine feed is 45%, the enzyme addition amount is 1%, and at the moment, the theoretical total phenol content is 45.40mg/g. The fermentation is carried out under the experimental conditions (the fermentation time is 7 days, the water content of the compound traditional Chinese medicine feed is 45%, the enzyme addition amount is 1%), the total phenol content is measured, the experiment is repeated 3 times, and the average value of the total phenol content in the fermented feed is 45.38mg/g and is close to the theoretical value (P is more than 0.05).
Example 6: feeding effect experiment of the product; the compound traditional Chinese medicine fermented feed additive prepared in the embodiment 1 of the invention is added into common aquatic feed to obtain mixed feed for feeding special aquatic animals, and the addition amount is 5% -25% (by weight) of the obtained mixed feed.
A turtle greenhouse culture pond applied to a microbiological institute at Jiangsu university is selected for experiments, the length of the culture pond is 1.57m, the width is 1.22m, the height is 0.72m, and the water depth is adjusted to be 0.5m. Three parallel groups are arranged in each group, 20 Chinese soft-shelled turtles with similar sizes and weights are cultured in each parallel group, the time is 2021, 10 months, 2022, 1 month, 15 days of preliminary experiments and 60 days of formal experiments. The average body mass (the male and female parts are half, the average body mass (200+/-15) g and the healthy Chinese soft-shelled turtle are randomly divided into two groups, namely an experimental group and a control group;
feeding 10% of fermented compound traditional Chinese medicine feed additive and 90% of full-value powder in an experimental group;
the control group was fed 100% full value powder. The feed formula of the Chinese soft-shelled turtle is shown in table 13, and the composition of the full-value powder is shown in table 14.
The experimental group and the control group are respectively fed with soft-dough feeds prepared according to the table 13 before the beginning of the experiment for domestication for 2 weeks, and the daily feeding amount is 2% of the weight of the Chinese soft-shelled turtle. Each group was at 11 daily after the start of the trial: 00-14: 00. 19:00-22:00 is respectively fed with soft-dough feed prepared according to table 13, the daily feed amount is 2% of the weight of the Chinese soft-shelled turtle, and a siphon is adopted to clean the residual feed after 1h of feeding. During cultivation, the pH of the water body is between 7 and 8.5, the dissolved oxygen amount is 3 to 5mg/L, the ammonia nitrogen is less than 2mg/L, and the water temperature of the water body is 30 ℃.
Table 13 Chinese soft-shelled turtle feed formula
TABLE 14 full value powder composition
The feed coefficient of the Chinese soft-shelled turtles is shown in Table 15. In the long-term feeding test, the known compound fermented traditional Chinese medicine feed additive has the main component of plant tissues, is not easier to be absorbed by animals than full-value powder (mainly animal protein), but has small difference between the feed coefficient of the experimental group and the control group. The possible reasons for this are that after the compound traditional Chinese medicine feed additive is fermented, secondary metabolites such as lignocellulose are produced by the fermentation strain, and lignocellulose components in the degradable feed are converted into easily absorbed saccharide substances; if the protease can degrade macromolecular proteins into small molecular peptides, the fermented traditional Chinese medicine feed additive is easier to be absorbed by organisms. In addition, the possible reasons are that the compound fermented traditional Chinese medicine feed additive contains rich viable bacteria, and the digestion and absorption functions of the compound fermented traditional Chinese medicine feed additive are improved along with the field planting of the trionyx sinensis in the intestinal tracts of the trionyx sinensis after the trionyx sinensis is ingested.
TABLE 15 feed coefficient of Chinese softshell turtles
Note 1: feed coefficient = feed consumption/weight gain x 100%
And (2) injection: the same letter for the same row of data indicates that the difference is not significant (P > 0.05), and the no-label indicates that the difference is significant (P < 0.05).
The intestinal canal slice of the Chinese soft-shelled turtle is shown in fig. 20. The pile height, crypt depth, pile height/crypt depth are shown in Table 16.
The small intestine is an important part for absorbing nutrients, and the villus height, the crypt depth and the villus height/crypt depth ratio of the small intestine are all important indexes for measuring the digestion and absorption functions of the organism. The longer the small intestinal villus, the larger the ratio of small intestinal villus height to crypt depth, which indicates the stronger the intestinal digestion and absorption function. The ratio of the small intestinal villus length, small intestinal villus height and crypt depth of the experimental group is larger than that of the control group, which proves that the compound traditional Chinese medicine fermented feed additive is beneficial to the absorption of Hua Bie intestinal tracts.
Table 16 influence of Compound fermented traditional Chinese medicine feed additive on the intestinal tract of Hua Bie
Note that: the same letter for the same row of data indicates that the difference is not significant (P > 0.05), and the no-label indicates that the difference is significant (P < 0.05).
The results of the blood cell measurement of the experimental group and the control group are shown in Table 17, and the number of white blood cells in the blood of the Chinese soft-shelled turtle in the experimental group is far smaller than that in the control group. White blood cells are an important ring in the immune function of Chinese soft-shelled turtles, and the white blood cells participate in the immune process, and the content of the white blood cells is increased, so that certain bacterial infection conditions can exist. Experimental results show that the compound fermented traditional Chinese medicine feed additive has the advantages of improving the immune function of Hua Bie and reducing bacterial infection to a certain extent. As can be seen from the number of erythrocytes, the number of erythrocytes in the experimental group was greater than that in the control group. Some researchers believe that erythrocytes, in addition to being involved in oxygen transport, may also be involved in immune function in the body. The experimental results of the embodiment show that the feeding of the compound fermentation traditional Chinese medicine feed additive has a certain gain effect on the hematopoietic function and the immune function of the Chinese soft-shelled turtle participated by the red blood cells.
Influence of Table 17 compound fermented traditional Chinese medicine feed additive on conventional indexes of Chinese softshell turtle blood
Note that: the same row of data marked letters indicates that the difference is not significant (P > 0.05), and the no mark indicates that the difference is significant (P < 0.05).
The biochemical indexes of blood of the Chinese soft-shelled turtles in the experimental group and the control group are shown in a table 18. Glutamic-pyruvic transaminase (ALT) and glutamic-oxaloacetic transaminase (AST) are mainly present in the cytoplasm and mitochondria of liver cells respectively, and are two important indexes for evaluating whether liver functions are normal or not [120]. When the liver is damaged, the permeability of the cell membrane increases and the transaminase activity increases [121]. ALT and AST in the experimental group were smaller than those in the control group. Experiments show that the compound fermented traditional Chinese medicine feed additive has a certain protection effect on liver functions of Chinese soft-shelled turtles. UREA (UREA), creatinine (CREA), uric Acid (UA) levels are associated with protein metabolism by renal function of trionyx sinensis [126]. Once renal function is reduced or lost, substances such as UREA, CREA, UA, which are different endogenous chemical components, are caused to accumulate in the blood, thereby causing hyperuricemia. The experimental results of the research show that UREA, CREA, UA of the experimental groups are smaller than those of the full-value powder, which indicates that the compound fermented traditional Chinese medicine feed additive can be better than the full-value powder in the aspect of preventing kidney injury. The content of Triglyceride (TG), high Density Lipoprotein (HDL), low Density Lipoprotein (LDL) is related to lipid metabolism. The triglyceride has the main function of storing and supplying energy, and experimental results show that the content of the triglyceride in serum in the experiment is equivalent to that in the control group, but HDL in the experiment is higher than that in the control group, and LDL in the experiment is lower than that in the control group. The high HDL content of the experimental group shows that the compound fermented traditional Chinese medicine feed additive has better gain effect in participating in the cholesterol metabolism of the Chinese soft-shelled turtles. The main function of LDL is to transport cholesterol to the inside of tissues, but when it introduces too much cholesterol, it is easily adhered to the wall of blood vessels to cause arteriosclerosis, so that the LDL content is not too high, and the LDL of the experimental group is lower than that of the control group. According to the measurement results, the TG content between the two groups is similar, HDL in the experimental group is higher than that in the control group, and LDL in the experimental group is lower than that in the control group. According to the result, the compound fermented traditional Chinese medicine feed additive is beneficial to regulating and controlling the blood fat of the Chinese soft-shelled turtle.
Influence of Table 18 compound fermented traditional Chinese medicine feed additive on biochemical index of Chinese softshell turtles
Note that: the same row of data marked letters indicates that the difference is not significant (P > 0.05), and the no mark indicates that the difference is significant (P < 0.05).
The serum antioxidant immunity index of the experimental group and the control group of Chinese soft-shelled turtles is shown in table 19. Lysozyme (LSM) in serum is an enzyme produced by monocytes, neutrophils and macrophages that lyses the bacterial cell wall. It is an important non-specific defensive factor and is also one of the important markers of the non-specific immune defensive level of aquatic animals. Experimental results show that the lysozyme activity of the Chinese softshell turtle fed with the compound fermented traditional Chinese medicine feed additive is far higher than that of a control group. The result can show that the non-specific immunity of the Chinese soft-shelled turtle can be improved to a certain extent when the compound fermented traditional Chinese medicine feed additive is fed as a long-term ration.
The Chinese soft-shelled turtle body contains a large amount of polyunsaturated fatty acids, which are easily oxidized, so that diseases are generated. The research shows that the antioxidant capacity is related to nonspecific immunity, improves the antioxidant capacity of organisms, and can excite the immune function of the organisms, thereby improving the immunity and disease resistance of the organisms. Therefore, the immune function of the soft-shelled turtle serum can be observed by measuring the antioxidant capacity of the soft-shelled turtle serum. The result of measuring the total antioxidant capacity (T-AOC) of the two groups of Chinese softshell turtle serum can prove that the antioxidant capacity of the Chinese softshell turtle serum of the compound fermented traditional Chinese medicine feed additive group is about twice as much as that of the whole-price powder group. Can be used for improving the oxidation resistance of the Chinese soft-shelled turtles by adding the compound fermented traditional Chinese medicine feed additive, thereby achieving the effect of enhancing the immunity of organisms.
Acid phosphatase (ACP) is a marker enzyme for lysosomal enzymes in macrophages, and is involved in the transfer and metabolism of phosphate groups in vivo, with release of ACP accompanying phagocytosis and encapsulation reactions of blood cells. Wei et al have found in studies of the relationship of ACP to immune response in mussels. When the mussel is damaged by the outside, the ACP activity of the mussel body can be increased. And will return to normal condition after the injury is recovered. The study of which suggests that ACP viability is related to the mechanism of body injury. The test result shows that the ACP activity of the Chinese soft-shelled turtle in the compound fermented traditional Chinese medicine feed additive group is slightly lower than that of the Chinese soft-shelled turtle fed with the full-value powder. The result shows that the Chinese soft-shelled turtle with the complete powder group may have some damage to the body. Experimental results show that the daily ration added with the compound fermented traditional Chinese medicine feed additive can reduce the damage condition of the body of the Chinese soft-shelled turtle in daily cultivation to a certain extent.
Alkaline phosphatase (AKP) is a very important enzyme for trionyx sinensis. It is involved in bone and dorsal forma-tion and calcium and phosphorus metabolism. AKP activity is one of the important indexes of calcium and phosphorus metabolism reflecting the activity and the formation of osteoblast. The deficiency of calcium and phosphorus has a great influence on animal growth, and is mainly manifested by abnormal bone structure, reduced appetite, osteomalacia, reduced production performance, etc. AKP in the blood of young animals is mainly from skeletal tissue, and as it grows to maturity, AKP from bone is continuously reduced. In the experiment, certain differences exist among the individual Chinese soft-shelled turtles, and the differences are particularly shown in a plurality of groups, so that the sizes of the individual Chinese soft-shelled turtles are too large. The AKP determination result also shows that the AKP activity of the soft-shelled turtle with smaller body size is greater than that of the soft-shelled turtle with larger body size. Therefore, the direct addition calculation of the average value thereof as the measurement result is not very accurate. The AKP activity of the test is compared with the weight of the soft-shelled turtle. The results show that AKP activities/weights of two groups of Chinese soft-shelled turtles are basically similar, and the results can indicate that the addition of the compound fermentation traditional Chinese medicine feed additive has no great influence on the formation of bones and the formation of the back nails of the Chinese soft-shelled turtles and the metabolism of calcium and phosphorus.
Table 19 Effect of Compound fermented traditional Chinese medicine feed additive on antioxidant immune index of Hua Bie serum
Note that: the same row of data marked with the same letter indicates that the difference is not significant (P > 0.05), and the marked or marked with different letters indicates that the difference is significant (P < 0.05).
Experimental results show that the long-term feeding of the compound fermented traditional Chinese medicine feed additive has no obvious influence on the production performance of the Chinese soft-shelled turtle. The compound fermented traditional Chinese medicine feed additive can effectively improve the intestinal function of the Chinese soft-shelled turtles, improve the immunity of the Chinese soft-shelled turtles, and has obvious effects of reducing body damage and improving the liver and kidney functions and blood sugar regulating capability of the Chinese soft-shelled turtles.
Example 7: pathogenic bacteria toxicity attack experiment 1
The compound fermented traditional Chinese medicine feed additive prepared in the embodiment 1 of the invention is added into common aquatic feed to obtain mixed feed for feeding special aquatic animals, and the addition amount of the mixed feed is 5-25% (by weight). The formula of the compound fermented traditional Chinese medicine feed additive is as follows: 50% of compound traditional Chinese medicine (20% of baical skullcap root, 12% of Chinese gall, 14% of wild chrysanthemum flower, 4% of humifuse euphorbia herb), 30% of soybean meal, 20% of secondary powder and 1% of compound enzyme. The biological feed formula comprises: 60% of bean pulp, 40% of secondary powder and 1% of compound enzyme. The fermentation conditions of the compound fermented traditional Chinese medicine feed additive and the biological feed are the same, and the difference is only that the formulas are different.
The young Chinese soft-shelled turtle with the average weight of 10+/-5 g is selected from the male and female half and healthy and active Chinese soft-shelled turtles. The feed is randomly divided into three groups, the same amount of A, B, C three groups of feeds are respectively fed, wherein A is 10% of the compound fermented traditional Chinese medicine feed additive, 90% of the complete powder group, B is 10% of the biological feed, 90% of the complete powder group and C is 100% of the complete powder feed. Each group was repeated 3 times, 30 Chinese soft-shelled turtles each.
Aeromonas hydrophila is added into daily ration at the beginning of the toxicity attack experiment, and the average pathogenic bacteria intake of each young turtle is about 108CFU, and then different daily ration is fed normally.
The toxicity attack experiment results are shown in Table 20, and the survival results of the young turtles on the seventh day of the toxicity attack experiment show that in the toxicity attack experiment process, the complete powder group of young turtles die largely, the biological feed group dies slightly, and the survival rate of the compound fermented traditional Chinese medicine feed additive group is highest.
After pathogenic bacteria are added, some young turtles in the full-value powder group can slowly move, float, and the individual parts of the body can be subjected to bacterial infection such as ulceration. The biological feed group is characterized by the occurrence of the above situation of individual young turtles. However, in the group of the compound fermented traditional Chinese medicine feed additives, obvious abnormality is not seen, and active eating is normal.
Table 20 Aeromonas hydrophila toxicity attack experiment
Note that: the same row of data marked letters indicates that the difference is not significant (P > 0.05), and the no mark indicates that the difference is significant (P < 0.05).
Example 8: pathogenic bacteria toxicity attack experiment 2
The compound fermented traditional Chinese medicine feed additive is added into common aquatic feed to obtain mixed feed for feeding special aquatic animals, and the addition amount of the compound fermented traditional Chinese medicine feed additive is 5% -25% (by weight) of the mixed feed. The formula of the compound fermented traditional Chinese medicine feed additive is as follows: 50 percent of compound Chinese medicinal materials (20 percent of baical skullcap root, 12 percent of Chinese gall, 14 percent of wild chrysanthemum flower, 4 percent of humifuse euphorbia herb), 30 percent of soybean meal, 20 percent of secondary powder and 1 percent of compound enzyme)
The young Chinese soft-shelled turtle with the average weight of 10+/-5 g is selected from the male and female half and healthy and active Chinese soft-shelled turtles. The feed is randomly divided into three groups, the same amount of A, B, C three groups of feeds are respectively fed, wherein A is 10% of the compound fermented traditional Chinese medicine feed additive, 90% of the complete powder group, B is 10% of the biological feed, 90% of the complete powder group and C is 100% of the complete powder feed. Each group was repeated 3 times, 30 Chinese soft-shelled turtles each.
Aeromonas hydrophila is added into daily ration at the beginning of the toxicity attack experiment, and the average pathogenic bacteria intake of each young turtle is about 1012CFU, and then different daily ration is fed normally.
The results of the toxicity attack experiments are shown in Table 21, the toxicity attack amount of pathogenic bacteria is increased in the toxicity attack experiment, the reduction of the survival rate of the young turtles in each group can be obviously observed, but the survival rate of the young turtles in the group of the compound fermented traditional Chinese medicine feed additive is still higher than that of the young turtles in other groups, and the compound fermented traditional Chinese medicine feed additive has better effect of resisting the infection of aeromonas hydrophila.
Table 21 Aeromonas hydrophila toxicity attack experiment
Note that: the same row of data marked letters indicates that the difference is not significant (P > 0.05), and the no mark indicates that the difference is significant (P < 0.05).
Example 9: pathogenic bacteria toxicity attack experiment 3
The compound fermented traditional Chinese medicine feed additive is added into common aquatic feed to obtain mixed feed for feeding special aquatic animals, and the addition amount of the compound fermented traditional Chinese medicine feed additive is 5% -25% (by weight) of the mixed feed. The formula of the compound fermented traditional Chinese medicine feed additive is as follows: 10 percent of compound Chinese herbal medicine (4 percent of baical skullcap root, 2.4 percent of Chinese gall, 2.8 percent of wild chrysanthemum, 0.8 percent of humifuse euphorbia herb), 54 percent of bean pulp, 36 percent of secondary powder and 0.1 percent of compound enzyme
The young Chinese soft-shelled turtle with the average weight of 10+/-5 g is selected from the male and female half and healthy and active Chinese soft-shelled turtles. The feed is randomly divided into three groups, the same amount of A, B, C three groups of feeds are respectively fed, wherein A is 10% of the compound fermented traditional Chinese medicine feed additive, 90% of the complete powder group, B is 10% of the biological feed, 90% of the complete powder group and C is 100% of the complete powder feed. Each group was repeated 3 times, 30 Chinese soft-shelled turtles each.
Aeromonas hydrophila is added into daily ration at the beginning of the toxicity attack experiment, and the average pathogenic bacteria intake of each young turtle is about 108CFU, and then different daily ration is fed normally. The results of the toxicity attack experiments are shown in Table 22, and the traditional Chinese medicinal materials adopted by the compound fermentation traditional Chinese medicine feed additive selected in the toxicity attack experiments only contain 10 percent, but the experimental results show that the compound fermentation traditional Chinese medicine feed additive still has good antibacterial effect.
Table 22 Aeromonas hydrophila toxicity test
The same row of data marked letters indicates that the difference is not significant (P > 0.05), and the no mark indicates that the difference is significant (P < 0.05).
Example 10: pathogenic bacteria toxicity test 4
The compound fermented traditional Chinese medicine feed additive is added into common aquatic feed to obtain mixed feed for feeding special aquatic animals, and the addition amount of the compound fermented traditional Chinese medicine feed additive is 5% -25% (by weight) of the mixed feed. The formula of the compound fermented traditional Chinese medicine feed additive is as follows: 90% of compound traditional Chinese medicine materials (36% of baical skullcap root, 21.6% of Chinese gall, 25.2% of wild chrysanthemum flower, 7.2% of humifuse euphorbia herb, 6% of bean pulp, 4% of secondary powder and 10% of compound enzyme);
the young Chinese soft-shelled turtle with the average weight of 10+/-5 g is selected from the male and female half and healthy and active Chinese soft-shelled turtles. The feed is randomly divided into three groups, the same amount of A, B, C three groups of feeds are respectively fed, wherein A is 10% of the compound fermented traditional Chinese medicine feed additive, 90% of the complete powder group, B is 10% of the biological feed, 90% of the complete powder group and C is 100% of the complete powder feed. Each group was repeated 3 times, 30 Chinese soft-shelled turtles each.
Aeromonas hydrophila is added into daily ration at the beginning of the toxicity attack experiment, and the average pathogenic bacteria intake of each young turtle is about 1012CFU, and then different daily ration is fed normally. The results of the toxicity attack experiments are shown in Table 23, and the content of the traditional Chinese medicinal materials adopted by the compound fermentation traditional Chinese medicine feed additive selected in the toxicity attack experiments is 90%, but compared with the traditional Chinese medicine additive group of 50%, the survival rate is improved by 6.67%, while the survival rate of young soft-shelled turtles is effectively improved, the additive cost is increased to a certain extent by the addition proportion, and economic factors need to be considered when the traditional Chinese medicine additive amount is adopted.
Table 23 Aeromonas hydrophila toxicity attack experiment
Note that: the same row of data marked letters indicates that the difference is not significant (P > 0.05), and the no mark indicates that the difference is significant (P < 0.05).
Description: the above embodiments are only for illustrating the present invention and not for limiting the technical solution described in the present invention; thus, while the invention has been described in detail with reference to the various embodiments described above, it will be understood by those skilled in the art that the invention may be modified or equivalents; all technical solutions and modifications thereof that do not depart from the spirit and scope of the present invention are intended to be included in the scope of the appended claims.
Claims (8)
1. A preparation method of a compound fermented traditional Chinese medicine feed additive for preventing and treating aeromonas hydrophila is characterized by comprising the following preparation steps:
(1) Preparing a fermentation medium: mixing the compound Chinese medicinal materials, bean pulp and secondary powder, adding cellulase, hemicellulase and tannase, and mixing to obtain a solid fermentation culture medium;
the weight percentages of the components of the fermentation medium are respectively as follows:
10-90% of compound traditional Chinese medicine;
6-54% of bean pulp;
4-36% of secondary powder;
the addition amount of the complex enzyme is 0.1-10%;
the compound Chinese herbal medicine consists of the following materials in percentage by weight: 4-36% of radix scutellariae, 2.4-21.6% of gallnut, 2.8-25.2% of wild chrysanthemum and 0.8-7.2% of humifuse euphorbia herb;
the complex enzyme consists of cellulase, hemicellulase and tannase;
(2) Respectively inoculating bacillus, saccharomycetes and lactobacillus into corresponding liquid culture mediums for activation culture to respectively obtain bacillus fermentation seed liquid, saccharomycetes fermentation seed liquid and lactobacillus fermentation seed liquid; the bacillus is bacillus subtilis; the saccharomycete is saccharomyces cerevisiae; the lactobacillus is Lactobacillus plantarum, lactobacillus fermentum and Lactobacillus rhamnosus;
(3) Inoculating the bacillus fermentation seed liquid, the saccharomycete fermentation seed liquid and the lactobacillus fermentation seed liquid obtained in the step (2) into the fermentation culture medium obtained in the step (1), regulating the fermentation temperature and the water content of the culture medium, uniformly mixing to obtain a fermentation mixture, and carrying out anaerobic fermentation under a closed condition to obtain the fermented traditional Chinese medicine feed additive for preventing and treating aeromonas hydrophila infection.
2. The method for preparing the compound fermented traditional Chinese medicine feed additive for preventing and treating aeromonas hydrophila, according to claim 1, wherein the bean pulp in the step (1) is required to be dried and ground into powder for use in use; the powder is obtained by sieving with 50-80 mesh sieve; the compound Chinese medicinal materials are ground into powder for use, and the powder is obtained by sieving with a 50-80 mesh sieve;
the mass ratio of the cellulase to the hemicellulase to the tannase is 2:2:3; in the complex enzyme, the enzyme activity of the hemicellulase is 5 ten thousand u/g, and the enzyme activities of the cellulase and the tannase are 1 ten thousand u/g.
3. The method for preparing the compound fermentation traditional Chinese medicine feed additive for preventing and treating aeromonas hydrophila according to claim 1, wherein the relation between the dosage of the bacillus fermentation seed liquid and the saccharomycete fermentation seed liquid in the step (3) and the fermentation culture medium is 0.1-9 ml:100g; the total number of viable bacteria of the bacillus and the saccharomycetes is 1.0x10 8 ~2.8×10 9 cfu/mL; the saccharomycete fermentation seed liquid is saccharomyces cerevisiae fermentation seed liquid;
the lactobacillus fermentation seed liquid is Lactobacillus plantarum fermentation seed liquid, lactobacillus fermentum fermentation seed liquid and Lactobacillus rhamnosus fermentation seed liquid, and the total number of viable bacteria is 1.5X10 8 ~3.5×10 9 cfu/mL, wherein the relation between the inoculation amount of the lactobacillus fermentation seed liquid and the fermentation medium is 0.8-5.7 mL:100g;
the volume ratio of the lactobacillus fermentation seed liquid to the bacillus fermentation seed liquid to the saccharomycetes fermentation seed liquid is 2:2:3.
4. the method for preparing the compound fermentation traditional Chinese medicine feed additive for preventing and treating aeromonas hydrophila according to claim 3, wherein the relation between the dosage and the fermentation culture medium of the bacillus fermentation seed liquid and the saccharomycete fermentation seed liquid during inoculation is 2ml:100g.
5. The method for preparing the compound fermentation traditional Chinese medicine feed additive for preventing and treating aeromonas hydrophila according to claim 1, wherein the water content of the fermentation medium in the step (3) is 40% -60%; the fermentation time is 5-20 days, and the fermentation temperature is 24-38 ℃.
6. A compound fermented traditional Chinese medicine feed additive prepared by the method according to any one of claims 1-5.
7. The use of the compound fermented traditional Chinese medicine feed additive according to claim 6 in preparing aquaculture feed for inhibiting aeromonas hydrophila.
8. The use according to claim 7, characterized in that the specific operations are: adding the compound fermented traditional Chinese medicine feed additive into aquatic feed to obtain aquaculture feed; the addition amount of the compound fermented traditional Chinese medicine feed additive accounts for 5% -25% of the weight of the mixed feed.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210754136.6A CN115088785B (en) | 2022-06-29 | 2022-06-29 | Preparation method and application of compound fermented traditional Chinese medicine feed additive for preventing and treating aeromonas hydrophila |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210754136.6A CN115088785B (en) | 2022-06-29 | 2022-06-29 | Preparation method and application of compound fermented traditional Chinese medicine feed additive for preventing and treating aeromonas hydrophila |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115088785A CN115088785A (en) | 2022-09-23 |
CN115088785B true CN115088785B (en) | 2023-10-10 |
Family
ID=83295235
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210754136.6A Active CN115088785B (en) | 2022-06-29 | 2022-06-29 | Preparation method and application of compound fermented traditional Chinese medicine feed additive for preventing and treating aeromonas hydrophila |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115088785B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115887523A (en) * | 2022-11-21 | 2023-04-04 | 江西省科学院生物资源研究所 | Method for performing aerobic and anaerobic combined fermentation on Chinese herbal medicine byproducts and application |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111011665A (en) * | 2019-12-31 | 2020-04-17 | 山西大禹生物工程股份有限公司 | Microbial fermentation wet material for promoting growth of aquatic animals and preparation method and application thereof |
CN113317413A (en) * | 2021-06-04 | 2021-08-31 | 江苏大学 | Processing method and application of hermetia illucens-based aquatic fermented feed |
-
2022
- 2022-06-29 CN CN202210754136.6A patent/CN115088785B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111011665A (en) * | 2019-12-31 | 2020-04-17 | 山西大禹生物工程股份有限公司 | Microbial fermentation wet material for promoting growth of aquatic animals and preparation method and application thereof |
CN113317413A (en) * | 2021-06-04 | 2021-08-31 | 江苏大学 | Processing method and application of hermetia illucens-based aquatic fermented feed |
Non-Patent Citations (2)
Title |
---|
不同益生菌发酵中草药对鲤鱼生长性能及抗感染能力的研究;赵倩,等;中国饲料(第2期);35-39 * |
斑点叉尾触"腹水症"病原的体外中药药敏试验;曹良,等;生态学杂志;第2卷(第1期);95-97页 * |
Also Published As
Publication number | Publication date |
---|---|
CN115088785A (en) | 2022-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111363698B (en) | Microbial inoculum for reducing mildew and mycotoxin harm of fermented feed and application | |
CN108013248A (en) | One boar fermentable fiber feed and preparation method thereof | |
CN102217708B (en) | Novel environment-friendly feed additive and preparation method thereof | |
CN104770575B (en) | A kind of Radix Astragali probiotics and its preparation method and application | |
CN105166459A (en) | Pig feed | |
CN103184174B (en) | Production method of bacillus subtilis biological agent used for sodium humate-containing feed in medium | |
CN107853478B (en) | Enzyme-containing Chinese herbal medicine fermented feed additive for reducing methane emission of cattle | |
CN109022333A (en) | A kind of preparation method and applications of composite microbial fermentation bacteria agent | |
CN103098986A (en) | Beneficial microorganism antibiont-free feed and preparation method thereof | |
CN108977397A (en) | A kind of bacillus solid formulation that feeding compound selenium-rich is prebiotic and preparation method | |
CN108967742A (en) | A kind of compound micro-ecological preparation used for aquiculture and feed | |
CN109123141A (en) | A kind of application of preparation method of fermented tcm dreg fodder and products thereof, product | |
CN102907585B (en) | A kind of middle pig probiotic vitamin premix and batch | |
CN115088785B (en) | Preparation method and application of compound fermented traditional Chinese medicine feed additive for preventing and treating aeromonas hydrophila | |
CN114601016A (en) | Probiotic fermented traditional Chinese medicine feed additive for livestock and preparation method and application thereof | |
CN103211098B (en) | Aflatoxin adsorbent and application | |
CN106047769A (en) | Bacillus coagulans-containing composite inocula and preparation method thereof | |
CN109943502B (en) | Probiotics, leavening agent and application in Chinese herbal medicine preparation | |
CN103301409A (en) | Composite preventing and treating shrimp secretly-dying disease and preparation method for same | |
CN114468124A (en) | Fermented Chinese herbal medicine feed additive for preventing and treating necrotic enteritis | |
CN113616715A (en) | Fermented traditional Chinese medicine oral liquid for treating piglet diarrhea and improving intestinal flora thereof | |
CN115211501B (en) | Preparation method and application of compound fermented traditional Chinese medicine feed additive for preventing and treating common intestinal pathogenic bacteria | |
CN112617037A (en) | Preparation and application of feed active humic acid composite microbial agent | |
KR20110069388A (en) | Method of preparing jujube probiotics using solid-state fermentation for livestocks and use of it | |
CN115708841A (en) | Compound preparation for degrading ochratoxin as well as preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |